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Introduction: Malnutrition is a health issue directly and indirectly contributing towards high rates 
of morbidity and mortality globally, particularly in developing countries.  South Africa (SA) is 
faced with a double burden of diseases with a high prevalence of both under and over nutrition. The 
high prevalence of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome 
(HIV/AIDS) in SA worsens undernutrition. HIV/AIDS increases nutrient requirements and 
inadequate food intake results in malnutrition. Nutrition support through food supplementation is 
important to combat the high prevalence of malnutrition in sub-Saharan African countries including 
South Africa. Thus, a groundnut-soya based supplementary paste, Sibusiso, has been produced.  
However, its nutritional composition and acceptability have not been studied.   
Objectives:  (i) To determine the nutritional composition and physical properties of a ready-to-use 
supplement, Sibusiso, (ii) To determine the sensory acceptability of Sibusiso among healthy 
subjects; and sensory acceptability and perceptions of Sibusiso by subjects treated for HIV and 
HIV/TB.  
Materials and methods:  The nutritional composition, colour and texture of Sibusiso and a 
commercial peanut butter (control) were analysed following standard procedures. A cross-sectional 
consumer acceptability test was done using a 5-point facial hedonic scale (healthy control group, n 
= 68; HIV, n = 88 and HIV-TB co-infection treated, n = 51).  A total of six focus group discussion 
sessions (HIV subjects = 4 sessions and HIV/TB co-infected subjects = 2 sessions) were also 
conducted.   
Results and discussions: The protein content of Sibusiso (16 g/100 g) was almost half that of the 
commercial peanut butter (control), (25 g/100 g).  However, Sibusiso contained 1.4 times more ash 
(4 g/100 g) and almost twice as much carbohydrate (40 g/100 g) compared to the commercial 
peanut butter (22 g/100 g).  The fat (40 g/100 g) and energy (2 624 kJ/ 100 g) content of Sibusiso 
was not substantially different from that of the commercial peanut butter which was 43 g/100 g and 
2 852 kJ/100 g, respectively.  The lysine content of Sibusiso (58 mg/g) was about 1.7 times higher 
than that of the commercial peanut butter.  The methionine (11 mg/g) and histidine (35 mg/g) 
content of Sibusiso was almost twice that of the commercial peanut butter, respectively.  The 




supplements such as Plumpy’nut
®
.  Sibusiso met the FAO/WHO/UNU recommendations for 
essential amino acids. The consumption of 50 g of Sibusiso per day may provide approximately 
35% of the Estimated Energy Requirements (EER) and 30% of the Recommended Dietary 
Allowance (RDA) for protein for adults. Sibusiso was brown in colour, similar to the commercial 
peanut butter.  Its textural attributes were found similar to that of the commercial peanut butter but 
harder and stickier.   
The acceptability of Sibusiso was significantly associated (p ≤ 0.05) with the health status of 
consumers.  Overall, Sibusiso was liked by 94% of HIV and HIV/TB individuals (mean score: 4) 
compared to 85% for the healthy group (control).  More than 90% of the HIV/TB and HIV treated 
individuals liked the taste compared to the control group (86%, mean score: 4).  The colour and 
mouthful were rated „good‟ by more than 80% of the HIV and HIV/TB group, mean score: 3, with 
only 68% among the healthy group, mean score: 4.1.   
Conclusion:  Sibusiso is a good source of nutrients and was found to be acceptable to HIV and 
HIV/TB treated consumers.  It may be effective in alleviating disease-related malnutrition among 
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INTRODUCTION, THE PROBLEM AND ITS SETTING 
 
1.1  Importance of the study  
Ready-to-use supplementary foods (RUSFs) were developed and consumed to prevent and alleviate 
malnutrition among children and adults [Scherbaum, Shapiro, Purwestri, Inayati, Novianty, Stütz, 
Yusran, Müller, Wirawan & Suryantan 2009; World Health Organization (WHO) 2007].  RUSFs 
have been produced in various forms such as compressed bars, biscuits and micronutrient powders, 
lipid-based nutrient supplements, and high-quality vegetable oil and pastes (de Pee & Bloem 2008) 
in response to the high level of malnutrition reported globally (Scherbaum et al 2009).   
 
Malnutrition, including over and under nutrition, is a health issue directly and indirectly 
contributing towards high rates of morbidity and mortality globally, particularly in developing 
countries (Müller & Krawinkel 2005).  Undernutrition, the focus of this study, is divided into 
micronutrient deficiencies and protein-energy malnutrition (PEM) (Grover & Ee 2009; Faber & 
Wenhold 2007).  According to the Food and Agriculture Organization of the United Nations (FAO) 
and the United Nations World Food Programme (WFP), in 2010, 925 million people were 
chronically and severely undernourished (FAO 2012).  The Food Insecurity and Vulnerability 
Information Mapping System (FIVIMS) further reported that 44% of these people were from the 
Central, Eastern and Southern Africa from which 40% of the population suffered from 
micronutrient deficiencies (WHO 2012; FIVIMS 2004).  Globally, it was reported that 
approximately two billion people, particularly women and children were iron deficient and 
approximately 230 million children were vitamin A deficient (WHO 2012).  Iron, vitamin A, zinc 
and iodine deficiencies were reported as the most common (Rosenberg 2007; Allen, de Benoist, 
Omar & Hurrell 2006).   
 
South Africa is faced with a double burden of diseases with a high prevalence of both under and 
over nutrition (Vorster 2010).  However, the effect of undernutrition is worsened by the high 
prevalence of Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome 
(AIDS).  HIV/AIDS increases nutrient requirements and inadequate food intake results in 




presence of energy demanding diseases and is common amongst poverty-stricken populations due 
to famine, drought, political unrest or social issues (MedlinePlus 2011).  An inadequate intake of 
foods high in vitamins and minerals such as meat, fish, poultry, eggs, milk and dairy products, 
vegetables and fruits is also common among poor individuals.  Access to these foods is affected by 
various factors (Allen et al 2006), amongst which is accessibility, affordability, availability and the 
lack of cold storage facilities (Shetty 2006).  These factors particularly affect people with a low 
income who consume unhealthy diets (Duvenage & Schönfeldt 2007; Allen et al 2006).  A finding 
that most developing countries were highly dependent on a monotonous diet based on cereals, roots 
and tubers has supported this (Tontisirin, Nantel & Bhattacharjee 2002).  Such foods contain low 
micronutrients and protein therefore sole consumption of this food results in malnutrition (Allen et 
al 2006).  In South Africa, the poor micronutrient containing foods that were reported to be 
commonly consumed were maize, samp, mealie rice or grits, white rice, dry beans and peanut butter 
(Duvenage & Schönfeldt 2007).  This applied to both rural and urban areas for individuals over the 
age of 10 years (Nel & Steyn 2002).   
 
Other factors that were reported to contribute to malnutrition were illnesses such as tuberculosis 
(TB) and HIV/AIDS, inadequate maternal and childcare practices, poverty and food insecurity, 
ignorance, social taboos and lifestyle choices (Mabaya, Jordaan, Malope, Monkhei & Jackson 
2010).  Intestinal infections such as diarrhoea enhance malabsorption thus resulting in malnutrition.  
According to Saunders, Smith & Stroud (2011) infections such as TB, malaria and HIV have the 
most drastic effect on malnutrition.  Malnourished individuals often experience body fat loss, 
visceral organ wasting and muscle wasting (Shetty 2006), which can be masked in obese individuals 
(Saunders & Smith 2010).  The extent to which an individual may suffer the consequences of 
malnutrition depends on factors such as age, gender, physical activity, the presence of infections, 
endocrine status and adequacy of the consumption of certain nutrients (Shetty 2006).  Illnesses 
normally reduce appetite, which affects intake and utility of food by the body (Saunders et al 2011).   
 
In order to alleviate malnutrition, the South African Department of Health developed the Integrated 
Nutrition Programme (INP) with short and long-term nutrition interventions [Department of Health 
(DOH) 1998].  The strategies or focus areas under the programme were the following: contribution 
to household food security; disease-specific nutrition support, treatment and counselling; growth 




support of breastfeeding; micronutrient malnutrition control; and food service management (Steyn 
& Labadarios 2002).  Recent reports have highlighted limited success for the current strategies 
towards meeting nutritional needs of their target groups (Swart, Sanders & McLachlan 2008).  The 
vitamin A supplementation programme under the micronutrient malnutrition control focus area was 
found to be unable to meet the needs of the most vulnerable children and post-partum women 
(Swart et al 2008).  Fortification of maize meal and bread flour with vitamin A, thiamin, riboflavin, 
niacin, vitamin B6, folic acid, iron and zinc was made compulsory in October 2003 in South Africa 
(Faber & Wenhold 2007; DOH 2002).  Food fortification was reported more effective when 
combined with supplementation.  However, recent data showed failure of the programme to meet 
anticipated results from the programme (Labadarios 2007).  The inability of fortified foods to offer 
the desired amount of energy, protein, fats and other elements obtained from a good diet for optimal 
health was amongst other reasons why the programme failed.  The programme might also not reach 
the targeted population especially the poorest part of the population due to affordability and access 
(Allen et al 2006).  The dietary diversity strategy on the other hand aimed at encouraging an intake 
of a variety of foods from different food groups and within different groups (Faber & Wenhold 
2007).  However, the effectiveness of this strategy has been limited by poverty and the lack of 
access to appropriate foods (Mayer, Pfeiffer & Beyer 2008).  These programmes and the rest of the 
INP focus areas seem to be particularly ineffective among vulnerable groups of people such as those 
infected with HIV and TB, who have higher nutritional needs.   
 
As mentioned previously, people infected with HIV/AIDS or TB experience a drastic increase in 
micronutrient and macronutrient requirements.  Physiological changes and the presence of 
opportunistic infections and side effects from the HIV/AIDS and TB medication are the reasons for 
the drastic increase [Regional Centre for Quality of Health Care (RCQHC) 2004].  As a result, in 
South Africa malnourished and wasted HIV or TB patients receive ready-to-use therapeutic foods 
together with medication during routine hospital or clinic visits (Oketch, Paterson, Maunder & 
Rollins 2011).  Ready-to-use therapeutic foods have been proven effective in improving the 
nutritional status of HIV or TB treated patients in other African countries such as Malawi, Niger, 






In 2004, a RUSF called Sibusiso was developed by the Gift of the Givers Foundation (GOTG).  The 
GOTG is a South African non-governmental organisation (NGO) and Africa‟s largest humanitarian 
and disaster relief organisation.  Sibusiso is produced in Malawi by a company called Rab 
Processors Ltd using locally grown groundnuts (Rab Processors Ltd 2011; GOTG 2009).  It is a 
peanut and soya paste fortified with micronutrients and macronutrients. The addition of 
macronutrients and micronutrients to food products has a tendency to alter the sensory properties of 
food products.  Sensory properties play a vital role in the eating and purchasing behaviour of 
consumers, which affects the acceptability of the product (Stone & Sidel 2004, pp13-15).  
According to Young, Blanco, Hernandez-Cordero, Pelto & Neufeld (2010), in order for a 
supplement to be effective it must first be acceptable to the target consumers and be regularly 
consumed.  It was also suggested that no food or beverage should be produced, distributed or 
marketed without studying whether its sensory properties are acceptable or not to the public (Stone 
& Sidel 2004, pp13-15).  There is a lack of data around the sensory acceptability of peanut-based 
RUSFs and the sensory acceptability of Sibusiso has not been studied in South Africa.  In this study 
the sensory acceptability and perception of Sibusiso by consumers with different health conditions 
such as HIV/AIDS and TB was assessed.  The physical properties of the product were also assessed 
to understand factors that may affect the acceptability of Sibusiso.  
 
1.2  Summary of research focus 
 
This study provided data on the nutritional composition of a RUSF, Sibusiso and the physical 
properties such as colour and texture of the product.  In addition, the sensory acceptability and 
perception of Sibusiso by healthy consumers and consumers treated for HIV/AIDS and HIV/TB co-
infection was determined.  Participants in the study were healthy adults from Pietermaritzburg, 
KwaZulu-Natal (KZN), and adult patients from Northdale and Grey‟s hospital in KZN.  
 
1.3  Purpose of the study 
 
The purpose of the study was to determine the nutritional composition and physical properties of 
Sibusiso and to assess the sensory acceptability and perceptions of Sibusiso by healthy consumers 





1.4  Study objectives 
 
The objectives of this study were: 
1.4.1 To determine the nutritional composition of the ready-to-use supplementary food,  
Sibusiso. 
1.4.2 To determine the physical properties of the ready-to-use supplementary food, Sibusiso, in 
terms of its colour and texture. 
1.4.3 To determine the sensory acceptability and perceptions of the ready-to-use food supplement, 
Sibusiso, by healthy consumers and consumers treated for HIV/AIDS and HIV/TB co-
infection.  
 
1.5  Hypotheses  
 
The hypotheses of this study were as follows: 
1.5.1 The nutritional composition of the ready-to-use supplementary food, Sibusiso, is  
superior to that of a commercial peanut paste due to the addition of micro- and 
macronutrients to Sibusiso. 
1.5.2 The colour and texture of the ready-to-use supplementary food, Sibusiso, is the same as that 
of a commercial peanut paste.  
1.5.3 Healthy consumers associate the sensory properties, colour, smell, texture and taste,  
of the ready-to-use supplementary food, Sibusiso, with that of a commercial peanut paste.    
1.5.4 Consumers treated for HIV/AIDS and HIV/TB co-infection associate the sensory 
properties, colour, smell, texture and taste, of the ready-to-use supplementary food, Sibusiso 
with that of a commercial peanut paste.  
 
1.6  Study parameters and general assumptions 
 
It was assumed that equipment used to analyse the nutritional composition, colour and texture of 
Sibusiso was accurate and reliable after calibration.  The consumer acceptability study was 
conducted in the UMgungundlovu District Municipality, KwaZulu-Natal, South Africa.  Consumers 
in the study were female and male adults between the ages of 18 - 55 years.  HIV/AIDS and TB 




bedridden.  It was assumed that consumers in the sensory evaluation understood the sensory 
properties assessed and were honest and objective when answering questionnaires.  Consumers with 
a peanut allergy were excluded from the consumer acceptability study.  
 
1.7  Abbreviations  
 
AOAC  Association of Official Analytical Chemists International 
ART  Antiretroviral therapy  
ARV  Antiretroviral drugs 
BMI  Body Mass Index 
CDC  Centers for Disease Control and Prevention  
DOTS  Directly Observed Treatment Short-course  
EER  Estimated Energy Requirements 
FAO  Food and Agriculture Organization 
FIVIMS Food Insecurity and Vulnerability Information Mapping System 
GOTG  Gift of the Givers Foundation 
HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome 
HPLC  High-Performance Liquid Chromatography  
INP  Integrated Nutrition Programme 
KZN  KwaZulu-Natal 
MUAC Mid-upper arm circumference 
NDF  Neutral Detergent Fibre  
NGO  Non-Governmental Organisation 
NPO  Non-Profit Organisation 
PEM  Protein-Energy Malnutrition 
PLWHA People Living With Human Immunodeficiency Virus/Acquired Immune   
  Deficiency Syndrome 
RCQHC Regional Centre for Quality of Health Care 
RDA  Recommended Dietary Allowance  
RUSF  Ready-To-Use Supplementary Food 
RUTF  Ready-To-Use Therapeutic Foods  




SCN  Standing Committee on Nutrition  
SPSS  Statistical Package for Social Sciences  
TB  Tuberculosis  
UKZN  University of KwaZulu-Natal 
UNICEF The United Nations Children's Fund 
USAID United States Agency for International Development 
WHO  World Health Organization 
WFP  World Food Programme  
 
1.8  Definitions 
 
Antiretroviral drugs:  Drugs that act against a retrovirus such as HIV, inhibiting its multiplication 
 at different stages of its life cycle (Stedman 2008).   
Healthy consumer:  For the purpose of this study it was an individual who presented no signs or 
 symptoms of illness and had not been diagnosed with or on treatment for any chronic 
 diseases, including HIV or TB.    
Malnutrition:  Imbalance, excess or lack of proper nutrient consumption leading to  
 overnutrition or undernutrition [World Food Programme (WFP) 2012].  
Opportunistic infection:  An infection that results when pathogens take advantage of a weakened 
 immune system, especially in the presence of diseases such as HIV (AIDS.org 2012).   
Quality:  For the purpose of this study quality was assessed by assessing the nutritional  
 composition, colour and texture of Sibusiso. 
Ready-to-use supplementary food:  High energy peanut based pastes fortified with high levels  
 of nutrients during processing, higher than in the normal fortification process, it is 
 used for the prevention of acute malnutrition or chronic malnutrition (Latham, Jonsson, 
 Sterken & Kent 2011).   
Ready-to-use therapeutic food:  It is a high energy and nutrient-dense food or food product 
 with a similar nutritional profile as that of the F-100 known to have special therapeutic 
 benefits, generally used in emergency situations and produced for treatment of severe 




Side effects:  Any reaction to or consequence of a medication or therapy.  Usually, although not 
 necessarily, the effect is undesirable and may manifest itself as nausea, dry mouth, 
 dizziness, blurred vision, discolored urine or tinnitus (Anderson 2009).   
Tuberculosis:  A disease that results from an infection with an organism called mycobacterium 
 tuberculosis, the tubercle bacillus, which can affect almost any tissue or organ of the 
 body, it mostly affects lungs (Avert 2012).   
 
1.9  Outline of the dissertation  
 
The lay out of the dissertation is as follows: 
Chapter 1: Introduction, the problem and its setting 
Chapter 2: Literature review 
Chapter 3: Methodology  
Chapter 4: Results 
Chapter 5: Discussion  
Chapter 6: Conclusions and recommendations 
 
This dissertation was referenced according to the guidelines used in the Discipline of Dietetics and 













   
2.1  INTRODUCTION  
 
In this chapter the prevalence of HIV and TB globally and in South Africa, its effect on food intake, 
the nutritional status of consumers and the nutritional needs of HIV/AIDS and TB infected 
consumers will be reviewed.  Available interventions to alleviate malnutrition, HIV and HIV/TB 
co-infection and limitations of these interventions that led to the provision of ready-to-use 
supplements to HIV/AIDS and HIV/TB co-infection treated consumers during routine clinic visits 
will be reviewed.  The effects of these supplements on the nutritional status and their acceptability 
to the targeted consumers will also be reviewed.  
  
2.2  PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS AND 
 TUBERCULOSIS  
 
Globally and specifically in SA, TB has been listed among the top ten causes of illnesses, death and 
disability and is the only infectious, curable disease accounting for the most deaths (Coovadia, 
Jewkes, Barron, Sanders & McIntyre 2009; Dye 2006; Davies 2003).  Approximately 9.4 million 
TB cases were reported in 2009 globally, representing an annually increasing rate of 137 cases 
among every 100 000 persons reported (WHO 2010).  Asia and Africa were reported to have the 
most new TB cases, with 55% and 30% cases, respectively.  South Africa is the third leading 
country in the world with 0.40 - 0.59 million TB cases after India with 1.6 - 2.4 million and China 
with 1.1 - 1.5 million cases (WHO 2010).  This is due to the high prevalence of HIV/AIDS which 
increases vulnerability to TB infection (Corbett, Watt, Walker, Maher, Williams, Raviglione & Dye 
2003).   
 
The mortality rate of HIV/TB co-infected individuals in Africa has been reported to be more than 
20 times higher than in the rest of the world (WHO 2010).  A person infected with HIV has a 
tenfold risk of developing TB compared to the uninfected (Sudarsanam, John, Kang, Mahendri, 




compromised immune system which exposes them to opportunistic infections such as TB (Lategan, 
Steenkamp, Joubert & Le Roux 2010).   
It was reported that approximately 30 - 50% of HIV infected individuals will later develop active 
TB while among TB infected individuals, 75% is HIV positive (WHO 2011a; Frieden, Sterling, 
Munsiff, Watt & Dye 2003).  There is difficulty and delay in diagnosing TB among HIV infected 
people and faster progression of TB in HIV infected individuals.  Among the new TB cases reported 
in 2009 globally, 13% of 9.4 million were HIV positive.  The WHO (2011a) reported that of 1.7 
million death cases due to TB, 400 000 were HIV infected.  The association between TB and HIV is 
serious as the high prevalence of people living with HIV presents a challenge in managing TB 
(WHO 2011a; WHO 2010). 
The increasing prevalence of HIV/TB co-infection is notable in Africa where the number of TB 
infected people with HIV is more than 60% in Botswana, Zambia, Zimbabwe and South Africa 
(Frieden et al 2003).  South Africa is the leading African country with the largest number of co-
infected adults of 2 million, followed by Nigeria with 0.9 million adults (WHO 2011b; Frieden et al 
2003).  The HIV/TB co-infection pandemic coupled with malnutrition has become a serious health 
problem in South Africa referred to as “triple trouble” (Chaparro & Diene 2009).  It was reported 
that individuals between the ages of 15 - 49 years were the most affected by the HIV/TB co-
infection (Frieden et al 2003).  KwaZulu-Natal, Gauteng and Mpumalanga in South Africa are the 
leading provinces with the number of co-infected individuals because of the fast-growing rate of the 
HIV infection (Fourie 2006).  Previously, the Western Cape Province had the highest rates of TB 
but has now been replaced by KwaZulu-Natal due to the poor TB programme performance 
indicators (DOH 2007). 
 
The high HIV and TB epidemic in South Africa is associated with the past oppressive era the 
country faced.  Until 1994, the apartheid era created social, economic and environmental conditions 
favourable to the development of TB and HIV transmission (Sudarsanam et al 2011).  Some of 
these conditions were overpopulation in shacks, migrant labour and dysfunctional health systems 
for the black population (Jinabhai, Coovadia & Abdool-Karim 1986).  During the apartheid era, in 
the first half of the 20
th
 century, the majority of black people migrated to big cities to work and were 




known as „town wives‟ who provided their service to workers.  The spread of TB and HIV 
transmission increased as workers habitually visited families and wives in rural areas (Kark 2003; 
Packard 1987).  It is because of this history that South Africa is still facing the HIV and TB 
pandemic to date (Karim, Churchyard, Karim & Lawn 2009).  HIV is commonly spread via 
heterosexual sex and through mother-to-child transmission (Avert 2011).  As a strategy to fight the 
high HIV/TB co-infection pandemic, the South African National AIDS Council (SANAC) called 
for the integration of care for both diseases at one hospital or clinic visit (SANAC 2011).  
According to SANAC people living with HIV with a CD4 count of < 350 cells/mm or have severe 
HIV disease irrespective of the CD4 count qualify to receive the antiretroviral therapy (ART) 
[Kaiser Family Foundation (KFF) 2011].   
 
2.3  NUTRITIONAL REQUIREMENTS IN HUMAN IMMUNODEFICIENCY VIRUS 
 
Nutritional requirements of people living with HIV/AIDS (PLWHA) depend on the disease stage 
according to the WHO classification of HIV stages and on the presence or absence of symptoms 
and side effects.  The protein, fat, micronutrient and energy requirements of infected individuals are 
reviewed in the next section. 
  
2.3.1 Energy requirements 
 
HIV patients have increased resting energy expenditure (REE) even when on treatment.  This 
increases energy requirements due to an increased amount of energy used for HIV infection and 
opportunistic infections (Castleman, Seumo-Fosso & Cogill 2004; FANTA 2004; WHO 2003).  It 
has been reported that energy requirements in people living with HIV at the asymptomatic stage 
(WHO stage 1) is 10% higher than that of healthy, uninfected individuals of the same age, gender 
and physical activity level.  This energy requirement should be met to maintain the body weight of 
HIV infected patients without manifested HIV symptoms (WHO 2003).  Furthermore, at the 
symptomatic stage (WHO stage 2 and above), energy requirements are further increased by 20% - 
30% more than that of healthy, uninfected individuals of the same age, gender and physical activity 
level (Avert 2011; FANTA 2004).  This is because of the increased energy demand due to 
opportunistic infections and diseases.  Fawzi, Msamanga, Spiegelman & Hunter (2005) reported 
that opportunistic infections can increase energy requirements by 50 - 100%.  However, such high 




the lack of adequate and nutrient-rich food intake, unavailability of nutrient-rich foods and 
metabolic changes such as; nutrient malabsorption and loss due to damaged intestinal cells, and 
impaired transport, storage and utilization of some nutrients (Castleman et al 2004).  Proteins, fats 
and carbohydrates provide the body with energy.  Carbohydrates are the major source of energy for 
the brain and nervous system, sustaining the digestive system and maintaining lean muscles.  
Digestible carbohydrates combined with protein and fats add bulkiness to food and contribute the 
most to energy for the body.  Indigestible carbohydrate such as fibre is important for other vital 
functions but provides little or no energy (Sizer & Whitney 2008, p104). 
 
2.3.2 Protein Requirements 
 
The WHO reported that there is inadequate data about increased protein requirements in people 
living with HIV/AIDS (WHO 2003).  The protein needs of PLWHA are the same as that of healthy, 
uninfected individuals of the same age, gender and physical activity level (Avert 2011).  This is so 
until further research is done to determine the optimal protein requirements during the course of the 
HIV disease.   
 
2.3.3 Fat requirements 
 
There is no data to suggest any difference in fat requirements between PLWHA and that of 
uninfected people (WHO 2003).  However, antiretroviral (ARV) drugs positively and negatively 
interact with foods that are high in fat, which suggests the importance of understanding specific 
interactions and consequences of specific drugs.  For example, an intake of foods high in energy, fat 
and protein may decrease the absorption of protease inhibitor (PI) drugs such as indinavir (Pronsky, 
Meyer & Fields-Gardner 2001).  On the other hand, such foods may increase the bioavailability of 
non-nucleoside reverse transcriptase inhibitor (NNRTI) drugs such as tenofovir.  Therefore, it is 
crucial to educate and advise patients about appropriate times to take specific drugs and fatty foods 
(FANTA 2004).  This is important to aid better nutrient utilisation, metabolism, distribution or 






2.3.4 Micronutrient requirements 
 
The micronutrient requirements of HIV infected adults are the same as that of healthy uninfected 
individuals of the same age, sex and physical activity level.  Patients should preferably obtain 
sufficient micronutrients from an adequate diet (WHO 2003).  However, pre-existing multiple 
micronutrient deficiencies of vitamins and minerals such as vitamin A, B-complex, C, E, selenium 
and zinc common in HIV infected individuals raises the need to consume multiple micronutrient 
supplements.  Failure to meet the micronutrient requirements amongst other things increases the 
progression of HIV to AIDS (FANTA 2004).  In order to meet the increased nutritional 
requirements it is vital to consume foods high in energy and micronutrients such as meat, fish, 
poultry, eggs, milk and dairy products, vegetables and fruits (Allen et al 2006).  However, PLWHA 
from undeveloped areas fail to meet the increased nutrient needs because of poor diet consumption 
(Castleman et al 2004; FANTA 2004).   
 
2.4  MALNUTRITION IN HIV AND TB INFECTION AND INTERVENTIONS TO 
 ALLEVIATE MALNUTRITION  
 
HIV, TB and malnutrition are inseparable, referred to as “triple trouble” (Chaparro & Diene 2009).  
Malnutrition, specifically undernutrition is common among HIV/AIDS and TB infected people 
because of physiological, socio-economic and psychosocial factors that accompany the infection.  
Reduction of food intake is the most important factor in disease-related malnutrition (Saunders & 
Smith 2010), because it weakens the immune system opening a gap for opportunistic infections.  
Infections such as TB affect appetite negatively due to changes in the secretion of cytokines, 
glucocorticoids, peptides, insulin and insulin-like growth factors which leads to decreased food 
intake (Avert 2011; Suttajit 2007).  Malnutrition is also worsened by the reduction of nutrient 
absorption and efficiency of utilization due to the injured lining of the intestines and increased 
energy expenditure during illnesses (Avert 2011; Hsu, Pencharz, Macallan & Tomkins 2005).   
 
2.4.1 Macronutrient deficiencies  
 
There is an increase in energy use and need for an HIV infected individual.  HIV infected 




insecure sub-Saharan Africa where the diet taken is generally low in energy and has no diversity 
(Sztam, Fawzi & Duggan 2010).  This accelerates disease progression, morbidity and mortality due 
to protein energy malnutrition (Hsu et al 2005).  The resting metabolic rate (RMR) increases during 
illness and HIV infected adults lose approximately 10% or more calories at rest or even higher in 
the presence of other infections.  Reduced protein and energy intake, physical activity, growth and 
diet-induced thermogenesis also contribute to weight loss and wasting (Hsu et al 2005).  More than 
10% weight loss is linked to a four-to-six fold higher risk of death for many HIV/AIDS infected 
patients.  This may be even worse in cases of HIV/TB co-infection (Avert 2011; Colecraft 2008).  
The effect is worsened by poverty, poor environmental conditions and low economic productivity 
(Gillespie & Kadayila 2005).   
 
2.4.2 Micronutrient deficiencies 
 
Micronutrients are important for the maintenance and function of the immune system 
(Cunningham-Rundles, McNeeley & Moon 2005; Scrimshaw & SanGiovanni 1997); however, their 
deficiency is commonly notable at the advanced stage of the HIV disease which increases HIV 
progression, transmission and mortality (Kupka, Msamanga, Spiegelman, Morris, Mugusi, Hunter 
& Fawzi 2004).  The lower serum concentration of micronutrients among HIV infected individuals 
may persist even during the intake of ART because of decreased food intake, increased nutrient 
needs, gastrointestinal malabsorption and body redistribution (Drain, Kupka, Mugusi & Fawzi 
2007; Shevitz & Knox 2001).  Deficiencies of thiamin, selenium, zinc, and vitamins A, B3, B6, B12, 
C, D, and E have been reported among HIV infected individuals.  There is an increase in 
micronutrient deficiencies among HIV and TB co-infected individuals which subsequently 
increases disease progression and wasting (van Lettow, Harries, Kumwenda, Zijlstra, Clark, Taha & 
Semba 2004).  It has been reported that micronutrient deficiencies are common among HIV positive 
people even before the infection, which worsens malnutrition and disease progression (FANTA 
2004). 
 
There is a need to consume sufficient amounts of macronutrients and micronutrients by HIV 
infected individuals because of the negative effect the infection has on the nutritional status 
(Castleman et al 2004; FANTA 2004).  The presence of opportunistic infections and side effects 




diets consumed by PLWHA from undeveloped areas fail to meet the increased nutritional 
requirements thus promoting disease progression (Castleman et al 2004; FANTA 2004).  According 
to FANTA (2004), nutritional support for PLWHA helps to manage HIV related complications, 
promotes good response to medical treatment and improves the quality of life (Castleman et al 
2004).  Suitable food supplements enriched with macro- and micronutrients to complement the diet 
are essential to improve the nutritional status of HIV and TB infected individuals (Lategan et al 
2010).  South Africa is faced with the challenge of identifying appropriate and affordable 
interventions to lower the prevalence of malnutrition among HIV infected individuals.  Current 
malnutrition interventions are reviewed next.   
 
2.4.3 Nutrition interventions to alleviate malnutrition in HIV and TB infection 
In 1995, the South African Department of Health developed an Integrated Nutrition Programme 
(INP) aimed at ensuring optimal nutrition, thus preventing and alleviating malnutrition among the 
general public (DOH 1998).  The INP has seven focus areas with different objectives to alleviate 
malnutrition.  The following focus areas aim to eliminate malnutrition among adults in the general 
public: firstly, contribution to household food security; secondly, disease-specific nutrition support, 
treatment and counselling; and thirdly, micronutrient malnutrition control (DOH 2001).   
The first focus area focuses on implementing any nutrition-related activities that may improve 
access to adequate food of good quality to meet dietary needs of the entire household at all times 
(DOH 2001).  The second focus area, disease-specific nutrition support, treatment and counselling, 
aims at lowering the prevalence of low birth weight babies.  It also aims at lowering underweight 
during pregnancy, malnutrition and the mortality rate of under 5 year olds and diseases of lifestyle 
associated with nutrition (Steyn & Labadarios 2002).  Thirdly, the micronutrient malnutrition 
control strategy, aims at eliminating micronutrient deficiencies of nutrients by implementing 
supplementation programmes such as the vitamin A supplementation programme, food fortification 
and promotion of dietary diversification and education (DOH 2001).   
The INP focus areas do not account for the increased nutrient needs of HIV and TB infected people.  
Therefore, the DOH, Social Development and Agriculture are collaborating in a programme that 
includes the National Emergency Food Programme (NEFP) and the Nutritional Supplementation 




eradicating malnutrition and food insecurity by giving fortified food supplements and micronutrient 
supplements (pill or syrup form) to all people with TB, HIV and AIDS (Figure 2.1) (Anon 2003).  A 
reduction in the impact of opportunistic infections and symptoms such as oral thrush, diarrhoea and 
fatigue has been reported due to the provision of supplements at clinics (Oketch et al 2011).  
Specialized highly fortified ready-to-use supplements have been proven effective in improving the 
nutritional status of consumers with severe chronic illnesses such as HIV/AIDS when concurrently 
given with the ART in other African countries (Ahoua, Umutoni, Huerga, Minetti, Szumilin, 
Balkan, Olson, Nicholas & Pujades-Rodríguez 2011; Ndekha, van Oosterhout, Saloojee, Pettifor & 
Manary 2009a; Ndekha, van Oosterhout, Zijlstra, Manary, Saloojee & Manary 2009b; Ndekha, 


















Figure 2.1: Nutritional response to malnutrition among HIV and AIDS (Anon 2003) 
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2.5  THE EFFECT OF HIV/AIDS AND TB TREATMENT ON NUTRITIONAL STATUS 
 
A good combination of adequate nutrition and treatment for HIV/AIDS and TB is crucial to 
improve the nutritional status and revitalise the weakened immune system, thus lowering the 
likeliness of co-infections.  It also manages opportunistic infections, and delays disease progression, 
thus improving the quality of life and survival (Chandra 1991).  Furthermore, it is crucial for the 
improvement of adherence to treatment (Chandra 1991).  However, Castleman et al (2004) reported 
that it is difficult to meet the nutritional requirements of HIV infected individuals because of  
metabolic changes such as; nutrient malabsorption and loss due to damaged intestinal cells, and 
impaired transport, storage and utilisation of some nutrients.  These changes are accompanied by 
poor appetite, oral sores, rash, nausea, diarrhoea, fatigue, chills, fever, night sweats, loss of taste 
sensation, and weight loss (Avert 2011; Norman, Pichard, Lochs & Pirlich 2008).  Such changes 
further affect the ability to meet nutritional requirements negatively especially because many 
PLWHA fail to acquire food with sufficient nutrients.  In addition to physiological changes that take 
place in the body infected with HIV, the treatment also presents side effects that directly affect food 
intake and adherence to medical treatment (United States Agency for International Development 
(USAID) 2008; Castleman et al 2004; Macallan McNurlan, Kurpad, de Souza, Shetty, Calder & 
Griffin 1998).  Common treatment side effects are rash, dizziness, anorexia, nausea, vomiting, 
diarrhoea, dyspepsia, abdominal pain, flatulence, dry mouth, loss of taste, constipation, stomatitis, 
anaemia, fever, and pancreatitis depending on the ARV drugs taken (Table 2.1).  All of these 
changes have an influence, mostly negative, on the nutritional status as dietary needs are more 



























2.6  USE OF SIBUSISO, A READY-TO- USE SUPPLEMENTARY FOOD TO 
 ALLEVIATE MALNUTRITION IN HIV AND TB PATIENTS 
 
2.6.1 Background of the development of ready-to-use supplementary foods to alleviate 
malnutrition  
 
In 1999, the WHO, WFP, United Nations Standing Committee on Nutrition (SCN) and the United 
Nations Children‟s Fund (UNICEF) modified their guidelines for the management of severe 
malnutrition (WHO 2007) by giving therapeutic milk to severely malnourished children between 6 - 
36 months of age.  The therapeutic milk was successful in alleviating malnutrition and was 
effectively employed in hospitals (Scherbaum et al 2009; Maleta, Kuittinen, Duggan, Briend, 
Manary, Wales, Kulmala & Ashorn 2004).  However, problems were encountered with the 
reconstitution of this product.  There was the need for clean safe water and supervision during 
reconstitution at the hospital and undesirable bacterial growth occurred when left unrefrigerated 
(Scherbaum et al 2009; WHO 2007).  The product also targeted severely malnourished children 
only (Isanaka, Roederer, Djibo, Luquero, Nombela, Guerin & Grais 2010), provided excess 
nutrients for moderately malnourished children, was expensive to produce and had a limited 
production capacity (Michaelsen, Hoppe, Roos, Kæstel, Stougaard, Lauritzen, Mølgaard, Girma & 
ARV DRUG SIDE EFFECTS 
Zidovudine (ZDV) Loss of appetite, anaemia, nausea, vomiting, fatigue, constipation, 
fever, headaches, changed taste, weight gain. 
Nevirapine (NVP) Nausea, vomiting, fever, weight loss. 
Efavirenz (EFZ) High blood fat levels, loss of appetite, nausea, vomiting, diarrhoea, 
flatulence, dizziness. 
Lamivudine (3TC) Nausea, vomiting, diarrhoea, anaemia, tiredness, abdominal pain, 
loss of appetite. 





Friis 2009; Ashworth & Ferguson 2009; de Pee & Bloem 2008).  These weaknesses led to the 
development of ready-to-use therapeutic foods (RUTFs) which have been proven to be acceptable 
to children and effective in alleviating malnutrition and from which ready-to-use supplementary 
foods (RUSFs) were developed (Isanaka et al 2010).  RUSFs are low nutrient containing 
supplements developed to prevent and alleviate malnutrition among children aged 6 to 36 months 
(Scherbaum et al 2009; WHO 2007) and adults (Ndekha et al 2009a). 
 
Ready-to-use supplementary foods are produced in various forms such as compressed bars, biscuits 
and pastes (de Pee & Bloem 2008).  In this dissertation, the focus will be on pastes.  RUSFs are 
made up of peanut or soya paste, milk or whey powder, vegetable oil, sugar and minerals and 
vitamins, providing 23 kJ/g or more of energy (Maleta et al 2004).  The peanut based RUSFs have 
several advantages compared to other supplements.  These include the low water activity in the 
product which inhibits bacterial growth even when accidentally exposed to contaminants (Briend 
1997); the supplement can be kept unrefrigerated for a number of months (GOTG 2009). It also 
does not require any cooking which spare heat sensitive vitamins and does not require any labour, 
fuel and water when given to people thus appropriate for poor households.  Moreover, it can also be 
issued at household level to people experiencing natural disasters and wars to meet the nutritional 
needs and prevent malnutrition in the affected area (Manary, Ndkeha, Ashorn, Maleta & Briend 
2004).  
 
Compared with therapeutic foods, RUSFs provide less energy when combined with the local diet in 
a small daily dose of the spread (Isanaka et al 2010).  This justifies the use of the spread as a 
preventative measure instead of treatment (Isanaka et al 2010).  According to Collins & Henry 
(2004) the process of producing this product is simple as local crops and basic technologies present 
in developing countries can be used.  The production of RUSFs has been said to be less costly 
compared to the production of RUTFs which has led to an increased interest to use the product in 






2.6.2 Existing ready-to-use supplementary foods used to alleviate malnutrition in HIV and 
TB adult patients  
 
The first ready-to-use therapeutic food, Plumpy’nut
®
, was developed in 1996 with the intention to 
treat severe acute malnutrition in children replacing the WHO F-100 (Troubé 2012; Nutriset 2010).  
This RUTF is a dark brown peanut based paste which targets children and adults.  It is produced in 
92 g sachets and comprises of a peanut paste, sugar, vegetable fat and skimmed milk powder, whey 
powder, maltodextrin, cocoa and lecithin enriched with vitamins and minerals.  The paste provides 
500 kcal (2093.4 kJ) of energy per 92 g (Nutriset 2010).   
One of the ready-to-use therapeutic supplements produced in South Africa is Imunut
®
.  It is 
enriched with protein, essential vitamins, minerals, energy and essential fatty acids and is targeted at 
children with acute malnutrition.  It is creamy and brown in colour made up of milk powder, 
sucrose, vegetable oil, peanuts, emulsifier and glucose powder (Diva 2011).  These supplements 
were produced according to the WHO/UNICEF/WFP/SCN specifications for RUTFs which state 
that a supplement should have a soft texture and should be crushable.  Supplements should also 
taste good, be appropriate for children to eat and at least half of their protein should come from milk 
products (Anon 2012; WHO/WFP/SCN/UNICEF 2007).  A peanut based ready-to-use 
supplementary food, Plumpy’ doz
®
, was developed and produced in Normandy, France to alleviate 
acute malnutrition among children between 6 - 36 months of age (Nutriset 2010).  This 
supplementary food was proven acceptable to children aged 6 to 36 months of age from Niger 
(Isanaka et al 2010).   
 
2.6.3  The effect of ready-to-use supplements on malnutrition  
 
The provision of a highly fortified ready-to-use food to malnourished children from Chad, Ethiopia, 
Senegal and Malawi resulted in an improved nutritional status (Isanaka et al 2010; Maleta et al 
2004; Collins & Sadler 2002; Briend, Lacsala, Prudhon, Mounier, Grellety & Golden 1999).  The 
positive effect of these highly fortified foods on children was associated with the fact that these 
were developed to suit children‟s preferences.  The product, Plumpy’nut
®
, was later modified for 
adults and was also proven to improve the nutritional status of HIV infected adults in Malawi, 
Uganda and Kenya.  The consumption of the supplement was associated with changes in the mid-




presence of diarrhoea and morbidity rate (Leyna, Mnyika, Mmbaga, Hussain, Klouman, Holm-
Hansen & Klepp 2007; Wheeler 1999; Kotler 1994).  
 
2.6.4 Acceptability of existing ready-to-use supplementary foods by patients 
 
Even though RUTFs have been proven effective in improving the nutritional status of HIV 
malnourished children and adults (Ndekha et al 2009a; Ndekha et al 2009b; Ndekha et al 2005), 
there is limited data on the acceptability of this food especially among adults on treatment for 
HIV/AIDS and HIV/TB co-infection (Dibari, Bahwere, Le Gall, Guerrero, Mwaniki & Seal 2012).  
 
In Kenya, a ready-to-use therapeutic food was given to HIV infected adults on ART to test its 
acceptability.  The study was conducted in Nyanza Province which had the highest prevalence of 
HIV infected people (15.3%) in 2007.  Fifty-six (56) HIV infected adults (28 HIV infected, 18 
HIV/TB co-infected, 2 carers and 8 health staff), aged 15 years or older with a BMI of <17 kg/m
2
 
and/or a MUAC of <185mm were supplied with four sachets of Plumpy’nut
®
.  The provision of the 
supplement was part of a food programme for HIV people by the Kenyan Minister of Health.  In 
this study, three qualitative tools were used to collect data namely; the focus group discussions, 
semi-structured interviews and directly undisturbed observations of the distribution and 
consumption of the product in the HIV/TB ward (Dibari et al 2012).  It was reported that 
participants perceived Plumpy’nut
® 
to be medicinal due to its recovery effect and its ability to give 
energy, enabling patients to resume normal household duties rapidly.  Recipients felt stigmatised as 
the food was given with HIV treatment and was thus considered a „medical drug prescription‟ 
(Dibari et al 2012; Ndekha et al 2009).  
 
The product was said to be unacceptably salty in taste which led to some patients mixing it with 
other foods which was against the instructions of taking the food.  Patients also mixed the food with 
other foods because of its monotonous nature which was boring in their diet.  This however 
compromised the efficacy of micro- and macronutrients and delayed nutrition rehabilitation.  The 
product was reported to be too sweet by some patients who suggested the addition of lemon juice.  
Patients also had a problem with the thick texture and suggested an improvement to a smoother 
texture so that the supplement would be easily swallowed (Dibari et al 2012).  The taste of the 




symptoms experienced by all patients on ARV treatment or maybe because the product was 
originally developed to meet preferences of severely malnourished children (Dibari et al 2012; 
FANTA 2004).   
 
In addition, oral thrush experienced by HIV patients also negatively affected the acceptability of the 
supplement by one out of 40 interviewed patients.  One of the recommendations received from the 
study was that the swallowing capacity of patients should be assessed and verified before 
supplements are given because hospitalised patients could not solely eat the RUTF.  These patients 
had to mix the supplement with water or porridge because of its thick consistency.  In addition, 
therapeutic foods traditionally developed for malnourished children should be improved to meet the 
palatability preferences expressed by adult patients (Dibari et al 2012; Koethe, Chi, Megazzini, 
Heimburger & Stringer 2009).  
Another study was conducted in the central region of Malawi in 2005 among 63 wasted HIV/AIDS 
infected adults, aged 29 to 44 years.  These participants were at stage 3 of HIV according to the 
WHO classification system of HIV, had a MUAC of <210mm, a BMI of <17 kg/m
2
 and had 
bilateral pitting oedema in their feet or legs.  More than 13.3% of the participants had started taking 
ARVs.  The study was conducted to assess the acceptability of a novel chickpea and sesame seed 
ready-to-use spread among wasted ART patients.  The supplement was given at the beginning of 
taking ARVs and continued for 14 weeks.  On admission to the study, participants were 
experiencing symptoms such as fever, diarrhoea, oral thrush, nausea and dermatitis, which are 
known to affect food intake.  Patients were given the supplement with a 960 mg daily dose of co-
trimoxazole prophylaxis to treat minor opportunistic diseases.  The acceptability of the RUTFs was 
assessed through discussions with patients and caregivers.  People living with HIV/AIDS accepted 
the locally produced supplementary food.  However, patients associated the supplement with minor 
gastrointestinal symptoms that did not affect the product intake as such symptoms were found 
common among HIV infected individuals.  It was found that patients from the study continued 
taking the supplement because its benefits outweighed its negative effects (van Oosterhout, Ndekha, 





No data was found on the consumer acceptability of ready-to-use supplementary or therapeutic 
foods in South Africa especially among consumers treated for HIV/AIDS and HIV/TB co-infection.  
It is important to assess product sensory characteristics to identify characteristics that may be 
unacceptable to consumers so that the product may be improved by the manufacturer.  It is also 
important to investigate this to determine whether the targeted group will use the product or not and 
also to estimate the market strength of the product.  In a study conducted in the United States, it was 
reported that the success rate of a new product in the market is 17%, which suggested an 83% 
failure rate if consumer research is not done (Sloan 1994).   
 
2.6.5 Sibusiso, a ready-to-use food supplement 
 
Sibusiso is a ready-to-use supplementary food that was produced by a South African NGO, Gift of 
the Givers foundation, to prevent malnutrition during illnesses and natural disasters.  It is a 
groundnut-soya based paste which makes it different from the existing RUSFs (GOTG 2009).  The 
use of soya improves protein quality in a product as soya beans are known to have the highest 
protein content among cereals and legumes (Yeh, Resurreccion, Phillips & Hung 2002).  Sibusiso is 
also made with soya milk extract, soya protein, oil (soya oil), sugar, vanilla flavouring and a 
vitamin and mineral premix.  Therefore, it is high in energy, protein and micronutrients.  The 
product is suitable for children from 9 months old to the elderly.  It has been used by the South 
African Department of Health as an effective nutrient supplement for individuals experiencing 
malnutrition, TB and HIV and AIDS (GOTG 2009).  Although Sibusiso has the potential to 
improve the nutritional status of malnourished patients, especially HIV and TB patients its sensory 
acceptability among these patients has not been studied.  The main ingredients used to make 
Sibusiso, such as peanuts and soya may influence consumer acceptability of the product.  Physical 
properties such as colour and texture of Sibusiso which are influenced by the chemical composition 
or ingredients used may also influence consumer acceptability of a product (Costell, Tárrega & 
Bayarri 2010; Pohjanheimo 2010).  It has been reported that consumers with HIV/AIDS and TB 
experience changes in sensory activities which negatively affects food perceptions and this is 
worsened by side effects from the medication (Saunders & Smith 2010).  Therefore, it is important 





In addition, it is important to assess the nutritional composition of Sibusiso in order to confirm 
whether the product meets the WHO/UNICEF/WFP/SCN specifications for ready-to-use 
supplementary foods.  According to Elmadfa & Meyer (2010), it is important to know the 
nutritional composition of a product to identify how the product would meet specific requirements 
in the diet of the target group.  Knowing the nutritional composition of the product also helps to 
understand how the product components may influence the planning of clinical and therapeutic diet 
(Elmadfa & Meyer 2010).  Sibusiso is marketed as a high energy and protein containing product (16 
g/100 g).  However, its protein quality judged by the amino acid profile has not been reported, 
therefore, it is important to know the quality of the protein and other nutrients contained in Sibusiso.  
This is important as the product targets consumers with high nutritional needs.  The knowledge of 
the nutritional composition of Sibusiso may also determine whether nutrition and health claims 
made about the product are valid (Gillespie, Kulkarni & Daly 1998).  Factors that influence the 
acceptability of a food product are reviewed in the next section.    
 
2.7  FACTORS AFFECTING FOOD ACCEPTABILITY 
 
Acceptability of a food product by consumers depends on its intrinsic factors such as chemical and 
physical properties and extrinsic factors such as: culture; country of origin; price; store name; 
media; nutrition information and claims (Pohjanheimo 2010; Conner & Armitage 2002, p5).  It also 
depends on sensory and psychological factors as shown in Figure 2.2 (Conner & Armitage 2002, 
p6).  Extrinsic factors generate expectations that can influence consumer behaviour, perception of 
product quality, purchase intention or product selection (Deliza & MacFie 1996).  Intrinsic factors 
conversely have been reported to have a greater effect on consumer‟s decision to like or dislike 
most food products than extrinsic factors.  These factors influence the likelihood of consumers 
purchasing or eating a product (Cardello 1994, p254; Shepherd & Sparks 1994, p204).  Common 
factors that affect the acceptability of ready-to-use supplements are addressed next and physical 



















Figure 2.2: Factors that influencing food acceptability (adapted Conner & Armitage 2002, p6). 
 
2.7.1 Physical properties of ready-to-use food supplements 
 
Physical properties such as texture, consistency, colour and viscosity of spreads have to be 
appropriate for use and meet consumer expectations of how spreads should be.  These properties are 
a manifestation of food chemical properties and composition that identifies a food product.  The 
quality of these properties affects acceptability of food as consumers desire specific properties from 
specific foods.  Generally, pastes such as the studied RUSF, Sibusiso, are solely eaten, used as 
spreads or added to watery foods which are commonly eaten by vulnerable groups (Briend 2001).  
These products have a high viscosity that allows the supplement to melt when added to these watery 
foods (Singh, Castell-Perez & Moreira 2000).  Familiar physical properties to consumers increase 
the level of product acceptability (Heldman 2004).  Physical properties of food are perceived and 






























appearance, texture, viscosity, taste and flavour (Khumalo, Schönfeldt & Vermeulen 2011; Ngqaka 
2008).  In the next sub-section physical properties such as texture and colour are reviewed. 
2.7.1.1 Texture 
Texture is the physical and sensory expression of structural, mechanical and external qualities of 
food.  These qualities are assessed using human senses such as sight (visual texture), sound 
(auditory texture), touch (tactile texture) and kinaesthetic (Szczesniak 2002; Lawless & Heymann 
1998, p379).  Lawless & Heymann (1998, p380) suggested that for some objects, only one of the 
human senses may be needed to perceive texture while a combination is required for other objects.  
Texture is among the most important food attributes following flavour and odour as the level of 
tolerance of poor texture may be higher than accepting a putrid odour (Szczesniak 2002).   
 
By looking at a food product consumers assess the visual texture which creates expectations of how 
the tactile texture or the mouth feel should be.  This is because of the tendency to associate specific 
types of texture with certain foods (Conner & Armitage 2002, p13).  For example when a consumer 
looks at a fresh apple, a crunchy texture may be expected however if this expectation is not met the 
fruit is likely to be unacceptable.  Product visual texture is a good indicator of food quality while 
colour and flavour indicates food safety (Lawless & Heymann 1998, p380).   
 
In addition, consumers like to have control over the food introduced to the mouth.  It is important to 
know whether the food is stringy, sticky or has foreign lumps or hard particles which may introduce 
fear of choking thus increasing the likeliness of food rejection (Conner & Armitage 2002, p13).  
Texture has various parameters depending on the structure of a food product. It encompasses 
tenderness, chewiness and spreadibility (Szczesniak 2002).  The importance of texture in the overall 
acceptability of foods varies with different types of foods.  For some foods it is more important 
while in other foods it may not be as important.  For example, it can be a dominant factor for potato 
chips and the least important factor for bread (Jaworska & Hoffmann 2008).  Consumer‟s liking of 
texture may also fluctuate with the development of new products or habits.  For example, vegetables 
in the past were preferred overcooked, soft and floury while current consumers prefer firm, juicy 
and crispy vegetables (Szczesniak 2002).  The hardness, consistency or viscosity of ready-to-use 




The visual and tactile texture of ready-to-use pastes has been associated with that of a commercial 
peanut butter spread.  These spreads have high fat content therefore their textural qualities are likely 
to be hard or soft, chewy, greasy, viscous, smooth, creamy or crunchy depending on the product 
(Drewnowski 1987).  The association of ready-to-use pastes with peanut butter set expectations for 
these spreads to be viscous, spreadable and appear like peanut butter.  The viscous nature of spreads 
increases their acceptability to consumers as viscous spreads are commonly associated with higher 
product quality (Cooper 1987).  Not meeting these expectations might lead to a lower evaluation of 
a product or product rejection by consumers (Jaworska & Hoffmann 2008; Conference Report 
2002; Szczesniak 2002).  Three novel amino acid-balanced peanut spreads fortified with: (i) 14% 
non-fat dry milk (NFDM) at a 40% total fat content (PSM); (ii) 19% roasted soybean at a 40.5% 
total fat content (PSSA) and (iii) 19% roasted soybean at a 44.5% total fat content (PSSB) were 
produced from Georgia, USA.  These peanut spreads were also fortified with vitamin A, B1, B2, B6, 
C, calcium and iron and had their texture, appearance and flavour profiles tested against that of a 
control (all peanut spread) to identify any changes and overall acceptability of the products (Yeh et 
al 2002).   
The study was carried out among 50 participants from Georgia, USA, 92% of which were 
Caucasians and 8% Asian.  Participants were between the ages 10-54 years and more than 90% of 
adults in the study had completed college studies or had higher degrees and were employed (Yeh et 
al 2002).  More details about the study are included in Table 2.2.  Based on the 9-point hedonic 
scale, consumers rated the texture of the all peanut control spread the highest, followed by similar 
ratings for PSM and PSSB.  When a descriptive test was done, the spread fortified with 19% roasted 
soybean at a 44.5% total fat content (PSSB) had the stickiest and softest texture compared to other 
spreads.  The all peanut control, PSM and PSSB were also acceptable to consumers with the control 
being liked the most.  The acceptability and the nature of the texture of PSSB were because of high 
fat content and soy protein in the spread.  The spread fortified with 19% roasted soybean at a 40.5% 
total fat content (PSSA) was not acceptable because of the low fat content, which resulted in low 
intensity of roasted peanut flavour and high intensities on mouthcoating, mouthdryness, and 








Study  Objectives Methodology Results 
1. Yeh et al (2002). 
 
1. Determine consumer 
acceptability of 3 amino acid-
balanced peanut spreads 
fortified with 7 vitamins and 
minerals, namely: PSM, PSSA 
and PSSB. 
2. Determine flavor and texture 
profiles.   
 
1. Sensory evaluation: 9-point hedonic scale and 
questionnaire. 
2.  Fat: Crude fat content of peanut, soybean and NFDM 
powder was extracted with petroleum ether using the 
Goldfisch apparatus (model 35001) according to 
AACC method number 30-20. 
3. Protein: The Dumas method.  
4. Colour evaluation: XL 800 series Gardner 
Colorimeter with XL845 circumferential Sensor was 
used to take Hunter colour values (Pacific Scientific, 
Bethesda, Md., USA). 
1. Sensory evaluation: Consumers liked the 
control and PSM the most; PSSB was rated 
slightly lower, but not significantly different 
from PSM.  Only PSSA was rated < 6 (neither 
like nor dislike).  
2. Protein: All 3 fortified peanut spreads had 
higher protein content and lower fat content 
than the control. 
3. Colour: The colour L* of 3 fortified peanut 
spreads was higher than that of the control. 
2. Mazaheri-Tehrani, 
Yeganehzad, Razmkhah-




1. Investigate the effect of whole 
soybean and soynut flour at 0, 
5, 15, 20 and 30% (w/w) 
added to peanut spread 
formulations by determining 
measurable quality 
characteristics as instrumental 
and sensory analysis. 
  
1. Sensory analysis: 15 panellists to determine textural 
characteristics; hardness, cohesiveness, adhesiveness 
intensity and flavour colour, aroma and preferences 
using 9-point hedonic scale.  
2. Fat: Determined by Soxhlet extraction with diethyl 
ether. 
3. Protein: Measured by microkjeldal.  
4. Sugar, ash & moisture content: Measured according 
to Iranian standard number 5690. 
5. Texture profile analysis: Universal Texture Analyser 
(CNS Farnell, UK) connected to a computer 
programmed with Texture Pro 
TM
 texture analysis 
software. 
1. Flavour: Ratings were the same as control for 
all peanut soy spreads except for Psn20 with 
the highest score. 
2. Colour and aroma: No difference was 
observed between different samples. 
3. Fat: The control had the highest fat content. 
4. Protein: Psw30 and Psn30 had the highest 
protein content.  Psn5 had the same protein as 
the control.  
5. Texture: Psn30 and Psw30 scored the highest 






In another study with similar findings, a peanut spread was replaced by two types of soy flour at 4 
levels (w/w), (i) Whole soybean flour at 5 (Psw5), 15 (Psw15), 20 (Psw20) and 30% (Psw30) and (ii) 
Soynut flour at 5 (Psn5), 15 (Psn15), 20 (Psn20) and 30% (Psn30).  The control had peanut spread 
without soybean flour (ps0) and nine samples were prepared in total (Table 2.2).  Both studies 
concluded that specific changes introduced to the spreads did not have a negative effect on the 
acceptability because consumers liked all the formulations.  It was also concluded that the substitution 
of peanut with soybean or soynut introduced more protein to the sample, which increased adhesiveness 
and all controls maintained the highest fat content.  There was limited data about the texture of ready-
to-use pastes apart from the knowledge that these are pastes.  In this study, the texture of Sibusiso was 
analysed instrumentally in comparison to that of a commercial peanut butter control.  The mouthfeel of 
Sibusiso was also assessed using a 5-point facial hedonic scale.   
 
2.7.1.2 Colour 
Colour is the perception formed when light interacts with an object by being; refracted, reflected, 
transmitted and/or absorbed.  This process is affected by the physical, chemical and spectral 
composition of a product.  It is also affected by the spectral composition of the source of light 
interacting with an object and the spectral sensitivity of the eyes of the observer (Loughrey 2002; 
Lawless & Heymann 1998, p408).  Colour is the first important physical characteristic exposed to and 
evaluated by consumers.  This is because consumers are attracted to the appearance of a food product, 
as this encourages or discourages consumers from buying or eating the product (Khumalo et al 2011).  
Compared to texture, consumer‟s tolerance of a defect colour, taste and flavour is extremely low.  An 
extreme shift in the colour of a food, even though accompanied by no change in flavour, can make it 
completely unacceptable to consumers (Yeh et al 2002).  
Ready-to-use spreads are associated with peanut butter spreads therefore their colour is expected to be 
light brown or brown as described by a trained panel in a descriptive quantitative analysis (Dubost, 
Shewelt & Eitenmiller 2003).  The Hunter Colour-difference values for quality assurance are used to 
assess the colour of commercial peanut butter spreads.  The Hunter Lightness values of different 
peanut spreads were measured using a colourimetre in various studies (Mazaheri-Tehrani et al 2009; 
Yeh et al 2002).  In the study conducted by Yeh et al (2002) an all-peanut control had the lowest L* 
(lightness) compared to 3 fortified peanut spreads, PSM, PSSA and PSSB.  The addition of NFDM to 
PSM was reported to have contributed to the highest lightness of the spread followed by PSSB and 





descriptively tested the all-peanut control had the highest rating for brown colour, followed by PSSA, 
PSSB and PSM rated the lightest in colour.  The different colour ratings however did not affect the 
acceptability of the products by consumers as all spreads were slightly liked.  The replacement of 
peanut spread with varying levels of soybean flour and soynut flour also seemed not to affect the 
colour and rating of a ready-to-use spread in another study (Mazaheri-Tehrani et al 2009).   
In conclusion, the addition of soybean or soynut flour of different proportions to peanut spreads did not 
affect consumer acceptability of the colour and the overall product.  The all-peanut control from both 
studies had the lowest L* value compared to other samples, therefore it can be concluded from the 
reviewed studies that the more peanut content in a paste the darker the sample.  The product used in 
this study, Sibusiso, has peanuts and soya as the main ingredients and the proportion of these 
ingredients may affect the colour.  In this study, the colour of Sibusiso was analysed instrumentally 
and sensorily using the 5-point facial hedonic scale. 
2.7.2 Psychological factors 
Food acceptability and consumer intake is also mostly influenced by psychological factors such as 
food preference, previous exposure, values, beliefs and attitudes towards the product (Asp 1999; 
Cardello 1994, p254).  Attitude is an expression of internal feelings, beliefs, values or perceptions 
about the attributes of a tested product by consumers, which influences the decision to like or dislike a 
product (Asp 1999).  This factor is not inherent but attained from personal experiences, exposure to 
what other people know and from the mass media (Johns & Kuhnlein 1990, p23).  This suggests that 
the attitude of consumers can be changed depending on the information given.  If consumers are 
informed about nutritional benefits of a food product their attitude towards the food may be positively 
or negatively influenced (Bagozzi, Gürhan-Canli & Priester 2002, p125).   
Another psychological factor that affects product acceptability is consumer beliefs about a product.  
Consumer beliefs about the food nutritional quality and health benefits are more significant than the 
accurate nutrition quality and health benefits of a product in making a decision to accept or reject 
(Ngqaka 2008).  Costell et al (2010) also added that valuable benefits of a product could not be more 
important than the nature of sensory properties.  This was observed in organic foods where consumers 
considered their sensory properties even though their nutritional value was perceived acceptable 





Giving ready-to-use spreads to patients on ARV treatment at a health institution resulted in beliefs that 
these supplements were medicinal (Dibari, Le Galle, Ouattara, Bahwere & Seal 2008).  The association 
of the spread with HIV/AIDS led to stigmatisation and consumers being ashamed of taking the 
supplement.  This affected consumer intake of the product, which ultimately affected the nutritional 
effect of the spread on the body (Dibari et al 2008).  In this study, some of the consumers had been 
exposed to Sibusiso in their local clinics and hospitals before participating in this study.  However, 
their perceptions of the product were not assessed, therefore in this study, beliefs and attitudes towards 
Sibusiso were qualitatively assessed in focus group discussions. 
 
2.7.3 Consumer related factors 
 
Furthermore, there are other consumer related factors that influence acceptability of a product.  These 
are the age, gender, social status, culture, values, psychological state; context within which a food is 
consumed and the health status of consumers.  Food habits, the component of culture, were described 
as “the culturally standardised set of behaviours” that influences consumer‟s food decisions.  These 
were found to be common among individuals who were reared within a given cultural tradition (Mead 
1943, p21, cited by Asp 1999).  The culture to which the consumers belong affects the use of specific 
foods, which also affects their food intake (Asp 1999).  For example, some cultures may not be 
familiar with consuming spreads solely but spreading on bread or adding to porridge, which could 
affect the efficiency of some supplements on the patients (Dibari et al 2012).   
 
The age and the health status of a consumer have been reported to have an effect on the selection and 
consumption of a product.  Healthy adults were more enthusiastic about adopting healthy diets than 
children and adolescents (Chambers, Lobb, Butler & Traill 2008; Hearty, McCarthy, Kearney & 
Gibney 2007; van den Bree, Przybeck & Cloninger 2006; Kearney, Kearney, Dunne & Gibney 2000).  
HIV infected consumers experience opportunistic infections and side effects, which causes sensory 
changes and affect the assessment of product acceptability (Avert 2011). 
 
Older consumers experienced difficulty in classifying odour, texture and the taste of a product.  
According to Koskinen & Tuorila (2005); Schiffmann & Graham (2000) and Zandstra & de Graaf 
(1998) there is an association between increasing age and decreased ability of odour classification, 





showed more positive attitude towards trying to eat healthy and consider it more important compared 
to males (Hearty et al 2007; Kearney et al 2000; Roininen & Tuorila 1999).  Furthermore, females 
tend to believe that healthy eating yields more benefits in European countries (Zunft, Friebe, Seppelt, 
de Graaf, Margetts, Schmitt & Gibney 1997).  In this study, the acceptability and perceptions of 
Sibusiso were assessed by consumers of different health status, age, both genders and different 
experiences with supplements. 
 
2.8  CONCLUSION 
 
A number of nutrition interventions were developed by the South African Department of Health to 
combat the high prevalence of HIV/AIDS, TB and malnutrition.  These strategies had shortcomings, 
which led to the failure to meet the increased nutritional requirements of HIV infected individuals.  As 
a result, the combination of ART with nutritional assessment, education and provision of RUTFs as a 
standard of care for malnourished HIV/AIDS and HIV/TB treated patients was adopted.  The RUTFs 
administered at clinics or hospitals have been proven effective in improving the nutritional status of 
HIV/AIDS treated consumers.  The high nutrient content of such supplements had a positive impact on 
opportunistic infections and side effects experienced by the HIV/AIDS and HIV/TB co-infection 
treated consumers.  Sibusiso, a ready-to-use supplementary food used in South African has been 
reported to be high in macro- and micronutrients according to the nutritional information on the label.  
Its nutritional composition was determined in order to confirm if the product meets the 
WHO/UNICEF/WFP/SCN specifications for RUTFs and was assessed in comparison to a commercial 
peanut butter to account for any physical differences between the products.  
 
To ensure that consumer needs and expectations of the new product are met, various consumer 
acceptability studies were conducted in different African countries.  Changes in the composition of 
peanut pastes were reported to have a slight but insignificant effect on consumer acceptability of these 
supplements.  However, some consumers reported RUTFs to be too sweet, too salty, monotonous and 
with an unacceptable consistency.  Consumers also felt stigmatised by the community when RUTFs 
were given with ART medication.  Studies showed the importance of studying physical properties of 






Therefore, in this study nutritional composition and physical properties of Sibusiso were assessed in 
comparison to that of a commercial peanut butter.  The consumer perceptions of Sibusiso and other 
factors that might affect the acceptability of Sibusiso have not been studied in South Africa.  This is 
especially so amongst HIV/AIDS and HIV/TB treated consumers who experience sensory changes and 










This chapter describes the materials and methods used in this study.  The chapter consists of three main 
parts, the determination of the nutritional composition; physical properties of Sibusiso; and consumer 












Figure 3.1: Experimental design 
 
3.1 Materials and methods  
3.1.1 Food samples  
 
The Sibusiso samples used in this study were donated by the NGO, Gift of the Givers Foundation, 
whose Head Office is in Pietermaritzburg, South Africa.  A smooth peanut butter bought from a 
supermarket in Pietermaritzburg was used as a control.  The control was selected because its texture 
and colour were most similar to that of Sibusiso compared to other brands.  Four ± 400 g of Sibusiso
 
from four different batches and 1 ± 400 g of commercial peanut butter was used to analyse protein, fat, 
ash, NDF, moisture content and gross energy.  Approximately 6 ± 50 g samples of Sibusiso from six 
different batches and 1 ± 50 g of the control were used to analyse physical properties.  All 
measurements were done three times per sample and recorded. 
Protein  
Fat  




Nutritional composition Consumer acceptability and 
perceptions 
5-point facial hedonic scale 











3.1.2 Nutritional analysis 
 
The protein, fat, ash, NDF, moisture content and gross energy was determined according to the Official 
Methods of Analysis of the Association of the Official Analytical Chemists (AOAC 2002).   
The moisture content of the samples was analysed by drying the sample in an air circulated hot oven at 
95ºC for 3 days (AOAC Official method 934.01) (AOAC 2002).  Fat content was measured by 
extracting fat according to the Soxhlett method using the Buchi 810 Soxhlett fat extractor (AOAC 
Official method 920.39) (AOAC 2002).  Total mineral content was measured as ash after incineration 
of the samples for 4 hours at 550
o
C (AOAC Official method 942.05) (AOAC 2002).  Fibre was 
determined as NDF on a Dosi-Fibre machine following the method explained by van Soest, Robertson 
& Lewis (1991).  Gross energy was measured with a LECO AC500 automatic bomb calorimeter.  The 
non-fibre carbohydrate content of the samples was estimated by difference (Mestrallet, Carnacini, 
Días, Nepote, Ryan, Conci & Grosso 2004).  Protein was analysed by the Dumas combustion method 
using the LECO Truspec Nitrogen Analyser (AOAC Official method 990.03) (AOAC 2002).  The 
amino acid content was analyzed by a reverse-phase High-Performance Liquid Chromatography 
(HPLC) Pico-Tag method for rapid analysis of amino acid by pre-column which was derivatised after 
acid hydrolysis (Bidlingmeyer, Cohen & Tarvin 1984). 
 
3.1.3 Physical properties 
3.1.3.1 Texture analysis 
 
A texture analyser (TA.XTPlus analyser, Stable Micro Systems) was used to determine the texture of 
Sibusiso using the TTC spreadabillity rig, Reference: HDP/SR.  Approximately 6 ± 50 g samples of 
Sibusiso from six different batches and 1 ± 50 g of the control were placed in female plexiglass cones 
for testing.  The probe was set to penetrate the sample to a depth of 25.0 mm at a force speed of 
0.5mm/s such that the sample flowed outward at 45° between the male and female cone.  The ease of 
the flow showed the degree of spreadability of the sample whilst the withdrawal of the male probe 
indicated the adhesive characteristics of the sample (Stable Micro Systems Ltd 2009).  Each sample 








3.1.3.2 Colour analysis 
The colour of the ready-to-use food supplement was measured in terms of the Hunter Lab colour 
system using a HunterLab ColorFlex instrument (Hunter Associates Laboratory, Inc., Reston, Virginia, 
USA).  In the HunterLab system, L* is a measure of lightness (0 = black to 100 = white), a* redness 
(+a = redness; -a = greenness), and b* yellowness (+b = yellowness; -b = blueness) (DeMan 1999, 
p237).  Calibration was done using a white reference tile (L*= 93.89, a*= -0.81 and b*= 1.93).  The 
sample was evenly spread on the bottom of the ColorFlex sample cup and three readings were taken.  
The sample was stirred to ensure uniformity before measurements.  The psychometric colour terms 







and Hue Angle = tan 
–1
 b*/a*, respectively (Yeh et al 2002).  
 
3.1.4 Consumer panel 
 
The consumer panel was made up of two groups of subjects: the control group which comprised of 
UKZN students (18 - 26 years old), UKZN staff members (26 - 52 years old) and workers at a local 
day-care (23 – 40 years).  The second group of panellists was the experimental group which comprised 
of patients from two local hospital clinics, Grey‟s and Northdale hospital clinic (Pietermaritzburg, 
South Africa).  The experimental group consisted of two patient types: HIV only patients and HIV/TB 
(co-infected) patients.  The HIV only patients were on ARVs drugs only, whilst the HIV/TB patients 
were on TB drugs.  An average of 50 or more participants per groups was targeted as this number of 
participants has been found acceptable in consumer acceptability studies (Stone & Sidel 2004, pp247-






















Figure 3.2: Sampling design for the consumer panel  
 
3.1.4.1 Recruitment of panellists  
 
The subjects were invited to be sensory evaluation panellists by word of mouth, written letters and 
adverts both at the university and hospital clinics.  The English and isiZulu letter versions of the 
invitation letter are shown in Appendix A and Appendix B, respectively.   
All co-infected panellists were recruited from Northdale hospital because it had significantly more 
patients per day (approximately seven) compared to Grey‟s hospital which had ≤ 2 patients.  Ten 
subjects from both the control group and HIV only patients were excluded.  Seven co-infected patients 
were excluded from the consumer panel.  The exclusions were due to different reasons such as; allergy 
to nuts, age above 55 years, incomplete forms, pregnancy and alcohol consumption on the day of the 
study.   
3.1.4.2 Site description 
The two hospitals, Grey‟s hospital and Northdale hospital are public hospitals under the 






treatments (HIV/AIDS and TB clinics).  Grey‟s Hospital is a regional tertiary level hospital providing 
20% regional and 80% tertiary services to patients under UMgungundlovu district (DOH 2012).  
Northdale hospital on the other hand is a district level hospital located close to an Indian-dominated 
residential area of Pietermaritzburg.  Both the Grey‟s and Northdale hospitals had Dietetics 
Departments where wasted or underweight patients received either ARVs or TB drugs, and dietary 
supplements such as RTUFS or porridge.   
3.1.4.3 Inclusion criteria  
The inclusion criteria for the experimental group was as follows: consumers had to have eaten peanut 
butter before and between the ages of 18 - 55 years, should not have smoked 30 minutes before 
participating in the study and should not have had a nut allergy.  For the HIV only patients, clinic or 
hospital cards were taken from the hospital staff by the researcher to confirm that the patients were 
receiving ARVs.  The HIV/TB patients had to produce the Directly Observed Treatment Short-course 
(DOTS) card as confirmation that they were receiving TB treatment.  Data was collected from October 
2011 to February 2012.   
The control group had to be consumers between the ages of 18 - 55 years of age and should have eaten 
peanut butter at some time before the study.  Consumers should not have been allergic to nuts, have 
smoked 30 minutes before participating in the study, be sick or taking medication for any chronic 
illnesses including HIV and TB treatment.  The selection criteria were verbally communicated to the 
subjects and clarified in the informed consent form.  All consumers who participated in the sensory 
evaluation had to be willing to sign the informed consent form (Appendix C - English version and 
Appendix D - IsiZulu version).   
 
3.1.5 Sensory analysis by the consumer panel 
 
All sensory evaluation sessions on the university campus or at the hospital clinics were held in a room 
where a booth was set up for each panellist to isolate him/her from other panellists.  The UKZN Food 
Science laboratory was used for the panellists forming the control group.  Before the evaluation of the 
samples started, the panellists were welcomed and asked to sign the informed consent form.  The 5-
point facial hedonic scale was explained to them and they were told not to communicate with each 
other.  Each panellist was supplied with a glass of water, plastic teaspoon, serviette, small polystyrene 





3.3).  Each session took a maximum of 30 minutes and was conducted by the researcher with the help 
of three trained research assistants.  
 
  Figure 3.3: Booth set up for each panellist  
A 5-point facial hedonic scale with ratings (5 = Super good, 4 = good, 3 = Maybe good or maybe bad, 
2 = bad, 1 = Super bad) (Appendix E – English version and Appendix F – IsiZulu version) was given 
to consumers to rate the acceptability of Sibusiso.  This scale is one of the most common hedonic 
scales that have been modified from the 9-point hedonic scale.  According to Moskowitz, Muñoz & 
Gacula (2004, pp150-154) few categories on the scale have been preferred by some researchers.  This 
is due to suggestions that consumers do not need as many as nine categories to rate acceptability and 
that too elaborative a scale may confuse consumers (Dubost et al 2003).  The sensory attributes 
evaluated were taste, smell, colour, mouthfeel (texture) and the overall acceptability of Sibusiso.  To 
simplify the results for easy interpretation, the 5-point facial hedonic scale data obtained were 
simplified to three scores.  A score ≥ 4 to 5 signified that the attribute was good and hence liked.  A 
score of three represented neutrality with respect to liking the product and lastly a score of ≤ 2 
signified that the attribute was bad or disliked.   
The questionnaires were written in English and translated into IsiZulu as the majority of the subjects 
were IsiZulu speakers.  The researcher explained the instructions written on the form and what the 
faces indicated in the local language.  Participants expressed their evaluations by placing a cross or 





evaluation venue their questionnaires were checked to ensure that there were no blanks or spoiled 
questionnaires.   
 
3.1.5.1 Consumer perceptions, attitudes and beliefs about Sibusiso 
The attitude, beliefs and perceptions of consumers about Sibusiso were assessed qualitatively through 
focus group discussions.  Focus group discussions also helped to further understand data collected 
quantitatively using the 5-point facial hedonic scale and were also used as a platform to get views of a 
group of people instead of individuals (Vos, Strydom, Fouche & Delport 2005, pp286-313; Babbie & 
Mouton 2001, p292).  Focus group discussions have between 6 - 10 people in order to ensure 
informative and inclusive discussions.  The average duration for each session should be between 45 - 
90 minutes long (Anon 2005).  In this study, focus group discussions where held with HIV only 
subjects who had or had never, before the study, consumed Sibusiso and subjects treated for the 
HIV/TB co-infection who had or had not consumed Sibusiso before the study.  Healthy consumers 
were not targeted for focus group discussions because Sibusiso was mainly developed for 
malnourished individuals therefore this study focused on these individuals.  A list of questions was 
developed (Appendix G – English version and Appendix H – IsiZulu version) to guide the facilitator 
through the focus group discussion process.  A pilot focus group discussion was conducted at the 
Northdale clinic using 6 HIV treated consumers.  This was done to familiarise the facilitator, recorder 
and the scribe with their roles and to clarify their responsibilities (Paterson 2006).  It was also done to 
evaluate if the predetermined questions were appropriate and effective to fulfil the purpose of the focus 
group discussions (Paterson 2006).   
 
3.1.5.2 Consumer food perception  
 
The perception of food by people differs with each consumer depending on a number of factors, 
including socio-economic factors, such as their experiences and personal situations.  Food physical 
characteristics, external factors such as the media and the environment influence consumer perceptions 
of food (Johns & Kuhnlein 1990, p23).  The panellists were asked to name spreads, supplements and 
immune boosters known and used by consumers, the reason for use and to name the one most liked.  
This was asked to understand how Sibusiso would fit into the diet of consumers and also to understand 






3.1.5.3 Consumer expectations of Sibusiso   
In order to assess consumer expectations of Sibusisoand learn what would be preferred by consumers, 
focus group discussion participants were asked about their expectations of the physical properties of a 
peanut-based paste.  The question was asked before Sibusiso was presented to the subjects, and when it 
was presented, the panellists were asked to sensorily evaluate the sample and to describe its sensory 
properties.  Consumers were also asked to suggest physical attributes that needed to be changed to 
meet consumer expectations. 
 
3.1.5.4 Consumer willingness to buy  
According to Al-Ghuraiz & Enshassi (2005) the willingness to pay is the total amount a consumer is 
willing to pay, sacrifice or exchange for a good or service (Al-Ghuraiz & Enshassi 2005).  It is an 
indication that the consumer likes a specific good or service in the presence of other goods or services 
and has the ability to pay for it (Whitehead 2005).  An assumption is made that consumers who report 
positively when asked about their willingness to pay should be prepared to pay for the product or 
service price when offered (Russell 1996).  The willingness to buy Sibusiso was assessed and 
consumers were asked to explain the reason the product would be bought, for what price and how the 
product would be used and potential users in the household.  In addition to the planned questions for 
the focus group discussions a question about stigmatisation of recipients of supplements came up and it 
was added to the list of questions for the participants.   
 
3.1.5.5 Recruitment of participants for focus group discussions  
A total of four groups were targeted for discussions: HIV only subjects who had never seen nor 
consumed Sibusiso; HIV only subjects who had consumed Sibusiso; HIV/TB co-infected subjects who 
had never seen nor consumed Sibusiso; and HIV/TB co-infected subjects who had consumed Sibusiso.  
Participants were recruited on a daily basis at Northdale hospital clinic.  The same inclusion criteria for 
the consumer acceptability study were used in addition to the fact that participants had to state whether 
they had consumed Sibusiso before or not.  Consumers were verbally invited to participate in the focus 
group discussions from different queues in the hospital clinic.  There were few positive responses from 
patients as most patients were anxious about the long queues and that the focus group discussion 





However, a total of 32 HIV only subjects participated in the focus group discussions.  The HIV only 
subjects were divided into four groups, each with 6 - 8 subjects.  The first three groups of the HIV only 
subjects consisted of subjects who had never seen and consumed Sibusiso before the study and the 
fourth group consisted of subjects who had consumed the product before the study.   
Fifteen (15) HIV/TB co-infected subjects were divided into three groups.  These groups were small 
with an average of five subjects in each group.  This was due to a small number of co-infected patients 
treated at the hospital clinic daily.  Data collected from one of these groups, which consisted of four 
subjects, was discarded as during the focus group discussion session one of the participants showed 
symptoms of being mentally disturbed.  As a result data was collected from a total of 11 subjects who 
belonged to the remaining two groups.  In these two groups of the co-infected subjects, one group was 
made up of subjects who had never seen and consumed Sibusiso before the study and the other group 
consisted of subjects who had consumed Sibusiso before the study.   
 
The focus group discussions were conducted in a staff lounge at Northdale hospital.  Eleven (11) chairs 
were arranged in a circle in the lounge.  Before the participants entered the venue, the consent form, 
demographics information questionnaire, pen/pencil and the sample were already set up next to each 
chair.  After entering the venue, participants were welcomed and were introduced to the facilitator, 
recorder and the scribe.  The purpose of the session was explained and ground rules were 
communicated.  According to Bloor, Frankland, Thomas & Robson (2001, pp51-52), a focus group 
discussion may be facilitated by anyone provided they ensure that the number of participants is 
appropriate, a proper venue is organised and predetermined discussion questions are available.  The 
facilitator guided the discussion, asked all the questions ensuring that the aim of the discussion was 
fulfiled and ensured that a relaxed atmosphere was maintained.  The focus group discussions were 
facilitated in IsiZulu because participants were IsiZulu speakers.  This was also done to ensure that 
participants fully understood the questions and could freely comment in their language which offered 
more in-depth information (Paterson 2006). The recorder recorded the whole focus group discussion 
session using a recording device and also kept time.  The scribe wrote down everything that was said 
during the focus group discussion and grouped similar comments from the discussions.  All 
participants filled in the informed consent form and the demographic information questionnaire 





session being guided by written questions on paper.  The participants were provided with a meal after 
each focus group discussion session.   
 
3.1.6 Ethical approval  
 
Ethics approval was obtained from the University of KwaZulu-Natal, Humanities and Social Sciences 
Research Ethics Committee (Reference number HSS/0374/011M) (Appendix K).  Approval to conduct 
research at the hospitals was obtained from Grey‟s and Northdale hospitals (Appendices L and M).  All 
participants had to sign a written consent form before participating in the study. 
 
3.1.7 Statistical analysis 
 
Standard descriptive statistics (means, standard deviations and t covariance) of the nutritional 
composition and physical properties data were calculated.  Data from the sensory evaluation 
questionnaires was entered onto a spreadsheet, cleaned and coded for analysis using the Statistical 
Package for the Social Sciences (SPSS) version 15.0 (SPSS Inc., Chicago, III, USA).  The LSD test 
was performed to compare means of different health statuses and the chi-square test was used to 
generate p-values to analyse the relation between the acceptability of Sibusiso in relation to the health 
status, age and gender of consumers.  Data from focus group discussions that was recorded by the 
recorder was listened to and common comments were grouped and then entered onto a spreadsheet.  
This data was also compared to notes that were taken by the scriber.  A Social Scientist helped with the 















4.1  Nutritional composition of Sibusiso 
Table 4.1 presents the results of the nutrient composition of a ready-to-use supplementary food 
Sibusiso and a commercial peanut butter.  The gross energy, protein, fat, neutral detergent fibre, ash 
and carbohydrate composition of Sibusiso across batches was similar, which suggested accuracy and 
consistency in the combination of ingredients during production.  Further comparison will be based on 
the mean across batches of Sibusiso in comparison to the commercial peanut butter mean values.  In 
general, Sibusiso had a lower gross energy, protein, fat and NDF content than the commercial peanut 
butter (control) but was higher in ash and carbohydrates.   
 
The protein content of Sibusiso (16 g/100 g) was almost half that of the commercial peanut butter.  The 
fat content of Sibusiso (40 g/100 g) was not substantially different from that of the commercial peanut 
butter (43 g/100 g).  The NDF content of Sibusiso (6 g/100 g) was about 4 times lower than that of the 
commercial peanut butter.  Sibusiso contained approximately 1.4 times more minerals (4 g/100 g) and 
had almost twice as much carbohydrate (39 g/100 g) compared to the commercial peanut butter.  The 
gross energy of Sibusiso (2 624 kJ/100 g) was slightly lower compared to that of the commercial 
peanut butter (2 852 kJ/100 g). 
 
When the energy content of Sibusiso was compared to the recommended intakes for healthy adults, the 
consumption of 50 g of Sibusiso per day was found to provide approximately 38% of the EER for 
female adults (data not showed) (Institute of Medicine 2005).  The consumption of 50 g of Sibusiso per 
day was found to provide approximately 25% of the EER for healthy male adults.  Sibusiso was found 
to provide approximately 14% and 17% of the RDA for protein (g/day) for adult males and females, 





Table 4.1:  Nutrient composition of a ready-to-use peanut based paste, Sibusiso
1
   
Sibusiso batches  Gross energy  
(kJ/100 g) 












1 2 640.0 ± 0.0 16.0 ± 0.2 42.0 ± 0.8 1.3 ± 0.0 4.0 ± 0.0 37.0 ± 0.5 
2 2 604.0 ± 0.1 16.0 ± 0.2 39.4 ± 0.6 2.0 ± 0.1 4.0 ± 0.1 39.0 ± 1.1 
3 2 630.0 ± 0.0 15.0 ± 0.3 40.0 ± 0.4 1.2 ± 0.1 4.0 ± 0.1 40.0 ± 0.8 
4 2 621.0 ± 0.1 16.2 ± 0.2 39.0 ± 1.1 2.0 ± 0.1 3.4 ± 0.0 39.4 ± 0.7 
 








2 852.0 ± 0.1 25.4 ± 0.1 43.2 ± 0.4 6.2 ± 1.0 3.0 ± 0.0 22.2 ± 0.1 
 




EER RDA  AI  EER 
Males     (age > 19 years) 12.8  56 g/day   38 g/day   130 g/day 
Females (age > 19 years) 10.1  46 g/day   12 g/day   130 g/day  
1
Mean ± SD (n = 3) is reported on fresh weight basis  
2
 Non-fibre carbohydrates calculated by difference 
3
CV coefficient of variation 
4







Table 4.2 presents the amino acid composition of Sibusiso and a commercial peanut butter.  
Sibusiso had a higher level of essential amino acids (393 mg/g protein) than the commercial peanut 
butter (292 mg/g protein) (Table 4.2).  The glutamic acid, aspartic acid and arginine were the 
highest in Sibusiso, similar to the commercial peanut butter.  However, the content of these amino 
acids was slightly higher in Sibusiso compared to the commercial peanut butter.   
The lysine content of Sibusiso (58 mg/g protein) was 1.7 times, substantially higher than that of 
commercial peanut butter.  The methionine content of Sibusiso (11 mg/g protein) was almost twice 
that of the commercial peanut butter.  The histidine content (35 mg/g protein) was also 1.3 times 
higher compared to the commercial peanut butter.  The content of threonine (42 mg/g) and leucine 
(86 mg/g protein) of Sibusiso was slightly higher than that of the commercial peanut butter.  This 
was also observed about phenylalanine (65 mg/g protein) and tryptophan (10 mg/g protein) when 
compared to the commercial peanut butter.  Sibusiso was slightly lower in valine (39 mg/g protein) 
than the commercial peanut butter (42 mg/g protein).  It also had a slightly low amount of arginine 
(109 mg/g protein) compared to 119 mg/g protein in the commercial peanut butter.  The high levels 
of amino acids in Sibusiso show a good quality of protein content compared to the commercial 
peanut butter (Table 4.1). 
Comparing the essential amino acid content of Sibusiso with the FAO/WHO/UNU, Sibusiso met all 
the FAO/WHO/UNU recommendations for healthy adults (WHO 2007).  An intake of 50 g of 
Sibusiso provides more than 55% of all essential amino acids except for valine (51%).  An intake of 
50 g of Sibusiso may provide up to almost 90% of histidine, isoleucine and tryptophan and 90% of 
threonine based on the FAO/WHO/UNU recommendations for healthy adults (WHO 2007).  











Mean ± SD (n = 2) is reported on fresh weight basis 
2
Percentage of RDA met when an adult above 19 years consumes 50 g of Sibusiso 
Amino acids (AA)  FAO/WHO/UNU for adults, 
>19 years (WHO 2007) 
% RDA met by 
Sibusiso
2 
 Sibusiso Peanut butter (commercial)   
Essential AA     
Methionine 11.1 7.0 10 56 
Histidine 35.2 22.3 15 85.0 
Threonine 42.0 32.0 23 90.2 
Valine 39.2 42.0 39 51.0 
Isoleucine 49.0 33.3 30 82.0 
Leucine 86.0 65.0 59 73.0 
Phenylalanine 65.0 51.0   
Lysine 58.0 34.0 45 64 
Tryptophan  10.3 8.0 6 87.0 
Total 395.0 292.4 227  
     
Non-essential AA     
Cysteine 18.0 14.2 6 66.3 
Aspartic acid 136.0 111.0   
Glutamic acid 224.0 206.0   
Serine 67.1 51.0   
Glycine 65.0 64.1   
Proline 63.0 46.0   
Arginine 109.0 119.0   
Tyrosine 40.0 34.0   
Alanine 50.1 41.3   





4.2  Physical properties of Sibusiso  
4.2.1 Colour  
The L* values of Sibusiso across batches were not very different (Table 4.3).  The a* and b* values 
of Sibusiso were also similar across batches.  Sibusiso had a brown colour, similar to that of the 
commercial peanut butter but lighter (Figure 4.1 and 4.2).  The chroma, degree of saturation of the 
colour of Sibusiso, and the Hue angle values were the same across Sibusiso batches.   
 




Mean ± SD (n = 3) is reported
 
2
 L* (lightness), 0 = black and 100 = white; a* (redness), +a = redness and –a = greenness; b* 
(yellowness), +b = yellowness and –b = blueness; chroma = [(a*) 2 + (b*) 2]
1/2














    Figure 4.1: Colour of Sibusiso 
                                   
Figure 4.2:   Colour of commercial peanut                                                             
       butter 
 
The lightness (L*) (57) of Sibusiso was not very much different from that of the commercial peanut 
butter.  However, the a* value of Sibusiso (6) was lower than that of the commercial peanut butter.  
Sibusiso also had a b* value (21) slightly lower than that of the commercial peanut butter.  The 
colour of Sibusiso was slightly saturated (7) compared to that of the commercial peanut butter.  The 
Hue Angle value of Sibusiso (73) was slightly higher than that of the commercial peanut butter.   
Sibusiso batches
2
 L* a* b* Chroma Hue Angle 
1 56.1  ±
 
0.0 6.1 ± 0.0 20.3 ± 0.0 7.2 ± 0.0 73.4 ± 0.0 
2  57.0  ± 0.0 6.3 ± 0.0 21.3 ± 0.0 7.4 ± 0.0 74.0 ± 0.0 
3 55.0  ± 0.1 6.3 ± 0.0 20.3 ± 0.0 7.3 ± 0.0 73.0 ± 0.0 
4 59.0  ± 0.1 6.1 ± 0.0 21.0 ± 0.0 7.3 ± 0.0 74.0 ± 0.1 
Grand mean  57.0  ± 0.1 6.2 ± 0.0 21.0 ± 0.0 7.3 ± 0.0 73.3 ± 0.0 
CV 2.0 0.0 0.0   
Peanut butter 
(commercial) 







The hardness and stickiness of Sibusiso across batches was not very much different (Table 4.4).  
The work of shear indicating the compression energy varied across batches of Sibusiso.  The 
hardness of Sibusiso (1.2 N) was almost the same as that of the commercial peanut butter.  The 
compression energy for Sibusiso was high (848 N) compared to that of the commercial peanut 
butter.  Sibusiso also had a higher stickiness (2 N) than the commercial peanut butter. 
    





batches Hardness (N) Work of shear (N) Stickiness (N) 
1 1.0 ± 0.0 
 
 746.3 ± 15.1 2.0 ± 0.0 
2 1.3 ± 0.0 932.2 ± 89.3 2.0 ± 0.0 
3 1.0 ± 0.0 721.0 ± 16.0 2.0 ± 0.0 
4 1.3 ± 0.0 994.0 ± 15.0 2.0 ± 0.0 
Grand mean 1.2 ± 0.0 848.2 ± 34.0 2.0 ± 0.0 
CV 0.0 4.0 0.0 
Peanut butter 
(commercial) 
1.1 ± 0.0 817.3 ± 21.0 1.3 ± 0.0 
1
Mean ± SD (n = 3) is reported 
 
4.3  Consumer sensory evaluation 
A total of 207 consumers aged 18 to 55 years participated in the study (Table 4.5).  These were 
grouped according to their health status as follows: the HIV treated group (n = 88), HIV/TB co-
infection treated group (n = 51) and the healthy group (n = 68).  Most consumers (n = 77) were 
between the ages of 26 – 35 years old.  The black race dominated the sample.  There was 190 












Table 4.5:  Demographic characteristics of the sensory panel  
 
Variables  n (%)* Variables  n (%)* 
Age  Race  
18 - 25 yrs 43 (21) Coloured  3 (1.4) 
26 - 35 yrs 77 (37) Indian 9 (4.3) 
36 - 45 yrs 51 (25.0) Black 190 (92.0) 
46 yrs and above 36 (17.4) White 5 (2.4) 
Gender   Health status  
Female 149 (72) Healthy 68 (33.0) 
Male 58  (28) HIV/TB 51 (25.0) 
  HIV 88 (43.0) 
Total  207 (100) 
* % of total sample (n = 207) 
4.3.1 Consumer acceptability  
The acceptability of Sibusiso was significantly associated (p < 0.05) with the health status of 
consumers (Table 4.6).  In terms of overall liking, 85% of the healthy group perceived Sibusiso as 
„good‟ compared to more than 90% in the HIV and HIV/TB co-infected group.  A similar trend of 
more consumers who rated attributes „good‟ from the treated groups compared to the healthy group 
was also observed for the taste, smell, colour, and the mouthfeel.  Approximately 88% of the HIV 
and HIV/TB treated groups rated smell „good‟ compared to 82% of the healthy group.  There was a 
lesser number of healthy consumers who perceived the colour (68%) and mouthfeel (70%) of 





Table 4.6:  Sensory perception of a ready-to-use peanut based paste, Sibusiso in relation to the health status, age and gender of              





















Sample size: Healthy group (n = 88); HIV group (n = 68); HIV/TB group (n = 51) 




















> 46yrs  
n (%) 





Overall liking    0.00     0.50   0.60 
     Bad 7 (10.2) 4 (5.0) 1 (2.0)  2 (5.0) 6 (8.0) 2 (4.0) 2 (6.0)  11 (8.0) 1 (2.0)  
     Neutral 3 (4.4) 4 (5.0) 1 (2.0)  2 (5.0) 4 (5.2) 1 (2.0) 1 (3.0)  5 (3.4) 3 (6.0)  
     Good  58 (85.2) 80 (91.0) 49 (96.1)  39 (91.0) 67 (87) 48 (94.1) 33 (92.0)  131 (89) 54 (93)  
Taste    0.02     0.30   0.30 
     Bad 7 (10.2) 5 (6.0) 1 (2.0)  3 (7.0) 6 (8.0) 1 (2.0) 3 (8.3)  11 (8.0) 2 (4.0)  
     Neutral 2 (3.0) 3 (3.4) 4 (8.0)  2 (5.0) 3 (4.0) 4 (8.0) 0 (0)  8 (5.4) 1 (2.0)  
     Good  59 (87.0) 80 (91.0) 46 (90.2)  38 (88.4) 68 (88) 46 (90.2) 33 (92.0)  128 (87) 55 (95.0)  
Smell    0.01     0.31   0.70 
     Bad 1 (1.4) 7 (8.0) 0 (0)  2 (5.0) 1 (1.3) 2 (4.0) 3 (8.3)  6 (4.1) 2 (4.0)  
     Neutral 11 (16.1) 4 (5.0) 6 (12.0)  8 (19.0) 9 (12.0) 2 (4.0) 2 (6.0)  16 (11.0) 5 (9.0)  
     Good  56 (82.3) 77 (88.0) 45 (88.2)  33 (77.0) 67 (87) 47 (92.2) 33 (92.0)  125 (85) 51 (88.0)  
Colour    0.00     0.05   0.34 
     Bad 9 (13.2) 9 (10.2) 3 (6.0)  7 (16.3) 8 (10.4) 3 (6.0) 3 (8.3)  19 (13.0) 2 (4.0)  
     Neutral 13 (19.1) 3 (3.4) 4 (8.0)  9 (21.0) 6 (8.0) 2 (4.0) 3 (8.3)  14 (10.0) 6 (10)  
     Good  46 (68.0) 76 (86.3) 44 (86.2)  27 (63.0) 63 (82.0) 46 (90.2) 30 (83.3)  114 
(78.0) 
50 (86)  
Mouthfeel    0.06     0.0   0.50 
     Bad 11 (16.1) 10 (11.3) 4 (8.0)  6 (14.0) 11 (14.3) 3 (6.0) 5 (14.0)  21 (14.3) 4 (7.0)  
     Neutral 9 (13.2) 2 (2.3) 4 (8.0)  10 (23.3) 1 (1.3) 2 (4.0) 2 (6.0)  11 (8.0) 4 (7.0)  





The colour and mouthfeel was also rated low (3.7) by the healthy group compared to the ratings of 
the overall product, taste and smell (Table 4.7).  The HIV/TB co-infected group also had a lower 
rating of colour (3.9) and mouth feel (3.9) compared to the ratings of other attributes.  This meant 
that healthy and HIV/TB co-infected groups moderately liked the colour and mouthfeel of Sibusiso.  
HIV consumers on the other hand rated all attributes equally high as the average rating was 4.2 on 












Age groups Taste Smell Colour Mouthfeel  Overall liking 












































Mean 4.2 4.1 3.9 3.9 4.2 
Health Status      

































Mean 4.2 4.1 3.9 3.9 4.2 
1
Mean of 207 evaluation, i.e n = 207 
2









Overall, more than 85% of all age groups perceived Sibusiso as „good‟.  The taste of Sibusiso was 
perceived „good‟ by approximately 90% of all age groups.  The taste of Sibusiso was perceived 
„good‟ by 90% of the 36 - 45 year old and the ≥ 46 year old groups compared to a lesser number 
from the 18 - 35 year old group.  The number of consumers who perceived the smell of Sibusiso 
„good‟ was lower (77%) from the youngest group (18 - 25 years) compared to other age groups 
with an average of 90%.  A significant (p < 0.05) association between the mouthfeel of Sibusiso 
and age groups was observed.  There was a lower percentage (63%) from the youngest group who 
perceived colour and the mouthfeel „good‟ compared to the average of other age groups (85%).   
 
The number of consumers aged 26 – 35 years and 36 – 45 years old liked the taste, smell, colour 
and mouthfeel the same.  However, for the youngest (18 – 25 years) and the oldest groups (≥ 46 
years) the number of consumers who perceived taste, smell, colour and mouthfeel as „good‟ 
decreased for the mouthfeel and colour.  The youngest and oldest consumers were more 
discriminative in their evaluation of attributes. All age groups had an average mean of 4.2 for the 
overall liking of Sibusiso.  This was similar to the rating of taste and smell (4.2 and 4.1 
respectively) for all age groups except (3.9) for smell from the youngest age group.  The colour and 
mouthfeel was rated lower (3.7) by the 18 – 25 year olds compared to other age groups with an 
average score of 4.  Therefore all age groups liked the taste, smell, and the overall product well and 
the colour and mouthfeel was liked moderately.     
There was no significant association (p < 0.05) between Sibusiso sensory perception and gender.  
Overall, approximately 90% of both genders liked Sibusiso.  More than 85% of both genders rated 
the taste and smell of Sibusiso „good‟.  The colour and mouthfeel were liked by 78% and 86% of 
females and males, respectively.  
Consumers from different health groups were asked to explain what they liked or disliked the most 
about Sibusiso.  Most consumers said they liked everything about Sibusiso more specifically the 
taste and smell (Table 4.8).  A small number of consumers disliked the sweetness, fattiness, colour 










Table 4.8: General expressions of like or dislike of Sibusiso from the consumer acceptability study 
Sensory attributes Like/Dislike Frequency 
Taste  Like Taste  78 
  Taste & smell 24 
  Taste & colour 3 
  Taste, smell & texture 5 
  Has a peanut butter-like taste 19 
 Dislike Taste  1 
  Grainy texture 8 
Texture Like Nutty 5 
  Too much sugar 3 
 Dislike Runny texture, smell & aftertaste 3 
  Mouthfeel 5 
  After taste, graininess & fattiness 7 
  Crunchiness 2 
  Too much sugar 14 
  Too much sugar & fat 6 
  Too much sugar & nutty 2 
Colour  Like Bland colour 3 
  Colour & smell 6 
 Dislike Bland colour 8 
Smell  Like Smell 10 
 Dislike Smell 1 
Other (s) Like Product 32 
  Everything 126 
  No comment 38 
 Dislike Product 3 
 
4.4  Focus group discussion demographic characteristics  
The demographic characteristics of consumers who participated in the focus group discussions are 
summarised in Table 4.9.  There were a total of 43 consumers, 77% (n = 33) females and 23% (n = 
10) males.  Thirty seven percent of consumers were between the ages of 26 - 35 years followed by 
28% of the 36 - 45 year olds age group.  The majority of participants were blacks, 95%, with only 
5% of coloureds.  The highest level of education for the majority of consumers was high school 
(54%) followed by primary school, only a few (5%) had tertiary education.  The unemployment 
rate was high amongst consumers with more than 60% unemployed.  More than 50% of the 
participants received government grants, 79% of which received child support grants.  Most 
households had an average of 6 family members and had more members between the ages of 6 – 17 
years (27%) and 26 – 45 years (25%) and fewer children less than 1 year (5%) and ≥ 46 years of 





Table 4.9:  Demographic characteristics of consumers interviewed in the focus group         

















* % of total sample (n = 43) 
The total number of focus group discussion participants per groups is summarised in Table 4.10. 
There was a total of 5 focus group discussion sessions conducted with varying number of 
participants per groups, ranging from 5 - 13 persons per group. 
 
  
Variable  Category n (%)* 
Age (years) 18 to 25  7 (16.3) 
26 to 35  16 (37.2) 
36 to 45  12 (28.0) 
> 45  8 (19.0) 
Gender Female 33 (77.0) 
Male 10 (23.3) 
Race Black 41 (95.3) 
Coloured 2 (5.0) 
Marital status Single 39 (91.0) 
Married 4 (9.3) 
Household size (N) 2-4 12 (28.0) 
5-7      18 (42.0) 
8-10 10 (23.3) 
11-15 3 (7.0) 
Household age structure (years) 0 - 1 14 (5.0) 
2 - 5 29 (10.2) 
6 - 17 76 (27.0) 
18 - 25 55 (19.4) 
26 - 45 72 (25.4) 
≥ 46 37 (13.1) 
Level of education Primary School 14 (33.0) 
High School 23 (54.0) 
Tertiary education 2 (5.0) 
No formal education 4 (9.3) 
Employment status Employed 17 (40) 
Unemployed 26 (61.0) 
Grant received Child support grant 19 (79.1) 
Disability grant 5 (21.0) 





Table 4.10:  Number of participants in the focus group discussions 
Name of group n (%)* 
HIV group session 1 9 (21.0) 
HIV group  session 2 10 (23.3) 
HIV group  session 3 13 (30.2) 
HIV-TB group 6 (14.0) 
HIV-TB group 5 (12.0) 
Total 43 (100) 
* % of total sample (n = 43) 
Prior to focus group discussions, the majority of participants reported in a questionnaire that they 
used supplements.  More than 70% of the consumers took multivitamin supplements that they 
received from the hospital as part of treatment (Table 4.11).  The least taken supplements amongst 
others were porridge, iron and protein supplements.  The majority of the participants received 
supplements monthly (71%) compared to (14%) who bought them.  Seventy one percent of the 































Questions  n (%) Questions n (%)  
Do you take supplements?  How often do you receive /buy supplements?  
Yes 35 (81.4) Receive:     Monthly 25 (71.4) 
No 8 (19.0)                    Sometimes 1 (3.0) 
Type of supplements used  Buy:            Monthly 5 (14.3) 
Multivitamins 29 (83.0)                    Sometimes 1 (3.0) 
Future life 1 (3.0)                    Every second week 3 (9.0) 
Porridge 1 (3.0) Type of supplement taken  
Iron 1 (3.0) Pills 32 (91.4) 
Porridge & multivitamin 1 (3.0) Tubs 1 (3.0) 
Protein supplement 1 (3.0) Porridge 1 (3.0) 
Sibusiso 1 (3.0) Pills & sachets 1 (3.0) 
Places where supplements are 
received /bought  
 Do you use immune boosters?  
Hospital 25 (71.4) Yes  4 (9.3) 
Supermarket 2 (6.0) No 39 (91.0) 
Clinic 2 (6.0) Type of immune booster used  
Pharmacy 4 (11.4) Cell food 1 (25) 
Clinic, pharmacy, supermarket 1 (3.0) Stameta 2  (50) 
Hospital , supermarket 1 (3.0) Module 8 1 (25) 
  Amount of money spent on supplements  R25 – 400.00 





Table 4.12 outlines responses to open-ended questions that were asked during focus group 
discussions.  Consumers mentioned multivitamins as the commonly taken supplements because 
they are freely given at the hospitals and clinics.  Before Sibusiso was revealed to consumers, 
consumer expectations of physical properties of a peanut-based paste were asked.  The majority of 
participants, the HIV treated and the HIV/TB co-infection treated mentioned that they would like 
the product to taste like peanut butter, be smooth and have a brown colour like peanut butter.  
When Sibusiso was then presented for the sensory evaluation consumers; the HIV treated group 
liked the taste of Sibusiso and associated it with the porridge received from the clinic.  Other HIV 





















Table 4.12:   Consumer‟s perceptions of Sibusiso from focus group discussions 




and preferences of 
spreads, supplements and 
immune boosters 
 
i. Commonly used spreads 
and reason for use 
HIV “Peanut butter, it has healthy fats and boosts the immune system.”  “Margarine, it‟s a common 
spread that can be used for cooking and baking.”   
“Jam, it is liked by children”.   
HIV/TB Margarine, peanut butter, jam and fish paste “because these are nutritious common spreads a 
household cannot live without”. 
ii. Commonly used 
supplements and reason for 
use 
 
HIV Multivitamins, “because they are freely given at the hospital”.  Syrup and porridge from the clinic 
and pharmacy.  
HIV/TB Multivitamins, “because they are good for you especially if you do not eat vegetables and they are 
free from the hospital”. 
iii. Commonly used immune 
boosters and reason for use 
HIV “Do not use because we were advised so by the nurses and the ARV drugs are sufficient to keep us 
well”. 
HIV/TB “Do not use because we were advised by nurses not to use, they are expensive and are 
unnecessary”.  
Consumer expectations 
and preferences of a 
peanut based product 
iv. How do you expect peanut 
paste to taste, smell, look 
(colour) like? 
HIV “The taste should be like peanut butter, smooth and have a nutty smell”.  “The colour should be 
brown and should not be too sweet”.  
HIV/TB “It should be like peanut butter, smooth and spreadable”. 
Consumer sensory 
perceptions of Sibusiso 
 
v. How would you describe 
taste, smell, texture and 
colour of Sibusiso 
 
HIV Taste: “It is like porridge we receive from the hospital, like peanut butter with a different smell. It‟s 
a bit bitter”.  
Smell: “It is nice”.  “It is like that of baby food and nutty”.   
Texture: “It‟s watery”.  “It is like maize meal with oil, has more powder than nuts”.  “It is rough or 
crunchy”.   “It‟s too oily for sick people”.  “It is nice but a bit choking”.  
Colour:   “It is ok”. 
HIV/TB Taste: “It is nice, tastes like porridge given at the clinic”.  “It is oily and cannot eat solely”.        
Smell:  “It is fine especially when compared to Sibusiso used to be given before”.  “It has a nutty 
smell”.   
Texture: “It is rough, makes me feel like vomiting”.  “It feels like its powder porridge with oil”.  “I 
do not have any problems with it, you can get used to the crunchiness over time”.     
Colour:  “It is similar to that of peanut butter”. 
vi. How would improve the 
product? 
HIV “I would like it smoother and less crunchy so that elderly people can eat it too”.  





Table 4.12:   Consumer‟s perceptions of Sibusiso from focus group discussions continued  
Consumer uses of 
Sibusiso 
 
vii. How would you use 
Sibusisoin your household 
HIV “I would mix it with porridge”.  “It can be used on bread, porridge, and baking”.   
HIV/TB “I would eat it as it is or on bread”.  “I would add on my porridge”. 
Consumer willingness to 
buy Sibusiso 
 
viii. How much would you pay 
for the peanut paste? 
 
HIV “It should be free at the hospital like before or be R5.00-R20.00 because that is the average price 
for peanut butter spreads”.  “I can buy for R12.99-R35.00 because of its nutritional value”. 
HIV/TB “It can be between R13- R50 because I know the benefits of the product”.  It has to be cheap 
because you will have to buy it more than once in a mouth and children will eat it too.  “It can be 
R20-R80 because I know the benefits of the product”. 
ix. Should the peanut paste be 
sold would you buy it?  
 
HIV “Yes due to its nutritional value”.  “The tub is big and looks expensive but I can when I get a job”.   
HIV/TB “Maybe if it is cheap, because it‟s given for free at the clinic”.  “Yes, I can buy it and use it 
sparingly”.  
Stigmatisation  x. Given the product would 
you be afraid to show your 
family and community 
members? 
HIV  “Before we accepted our status we would have a problem showing people our medication and 
supplements but we do not care now”.  “People do not judge anymore like before”. 
HIV/TB “I would be shy to carry it if I was not open about my status”.  “I do not have a problem; my 












The HIV treated consumers liked the smell of Sibusiso and some associated it with that of baby 
food and said “it is nutty”.  Texture was generally said to be rough, crunchy and oily by some 
consumers.  The colour was liked and associated with that of peanut butter.   
The HIV/TB co-infected group also liked the taste of Sibusiso and associated it with that of peanut 
butter and the porridge received from the clinic.  These consumers also reported the smell and 
colour of Sibusiso to be nutty and like peanut butter, respectively.  Both the HIV and HIV/TB 
treated groups suggested a change of texture to smooth as both groups considered the texture to be 
rough, crunchy and oily.   
Regarding the willingness to buy Sibusiso, both groups agreed that they would buy Sibusiso. 
However, some consumers from the HIV/TB treated group showed the willingness to buy Sibusiso 
only if it were cheap and affordable to them.  The HIV treated consumers suggested that the 
product should have a price ranging from R5.00 - R35.00 while the HIV/TB treated group 
suggested a price range of R13.00 – R80.00.  Most HIV treated consumers suggested that Sibusiso 
should be given freely at the hospital.  Consumers from both groups suggested the price for 
Sibusiso based on the amount of money spent buying peanut butter.   
Some consumers from the HIV/TB treated group were willing to pay more for Sibusiso.  These 
were mostly consumers who had taken Sibusiso before and observed its effect on improving their 
health.   
Consumers reported large amounts of money spent on spreads and supplements, ranging from 
R4.00 - R400.00 monthly with an average of R150.00 (Table 4.11).  Peanut butter, jam and 













Table 4.13:  Spreads used by HIV and HIV/TB co-infected people in the households 
Spreads HIV/AIDS group  
(n = 11) 
HIV/TB group 
(n = 32) 
Total 
 n = 43 (%)* 
Butter 4 16 20 (47.0) 
Cheese spread 9 7 16 (37.2) 
Cream 5 0 5 (12.0) 
Fish paste  4 6 10 (23.3) 
Honey 7 3 10 (23.3) 
Jam 10 24 34 (79.1) 
Liver paste 2 1 3 (7.0) 
Margarine 10 22 32 (74.4) 
Marmite 2 1 3 (7.0) 
Mayonnaise 8 20 28 (65.1) 
Meat paste 2 1 3 (7.0) 
Peanut Butter 10 29 39 (91.0) 
Sandwich spread 4 2 6 (14.0) 
Syrup 2 0 2 (5.0) 
Vegemite  2 1 3 (7.0) 
Others 0 0 0 
Amount of money spent on 
spreads 
  R4.00 – 400.00 
* % of the total of both the HIV/AIDS and HIV/TB groups (n = 43). 
 
Consumers in the focus group discussions reported no fear of being stigmatised when receiving 
supplements from the hospital or clinic.  This was so because these consumers were comfortable 
with their HIV status.  Consumers further explained that HIV patients are no longer stigmatised like 
in early years when communities were still not well informed about the infection.  These consumers 
also explained that the response of HIV infected people to stigmatisation depends on their 















5.1  Nutritional composition of Sibusiso  
 
The nutritional composition of Sibusiso was compared to that of existing ready-to-use food 
supplements.  The protein content of Sibusiso was slightly higher than that of an internationally 
used ready-to-use therapeutic food, Plumpy’nut
®
 (Latham et al 2011).  The higher protein content 
may have been due to the use of soy protein extract in Sibusiso compared to Plumy’nut
®
 which 
used peanuts only as the main ingredient (GOTG 2009).  Sibusiso was found to meet the WHO‟s 
specifications for ready-to-use supplements in terms of protein content.  The WHO specifies 
protein content between 12.8 – 16 g per 100g of a product (WHO/WFP/SCN/UNICEF 2007).  This 
makes Sibusiso a suitable ready-to-use supplement to help alleviate malnutrition just as 
Plumpy’nut
®
 has been proven a competent ready-to-use therapeutic food globally (Manary et al 
2004).  
 
The protein content of Sibusiso that was used in this study appeared very much similar to that 
reported on the label of the commercialized one.  Sibusiso contains sufficient protein as a ready-to-
use supplement to improve the nutritional status of the HIV and HIV/TB treated patients and 
improve the BMI (Manary, Ndekha & van Oosterhout 2010; Manary et al 2004).  Protein intake is 
essential for the prevention of muscle loss, maintenance of a stable weight and the improvement of 
wound healing.  Protein is also important for strengthening the immune system thus improving 
recovery from infections (DOH 2001).  The food based dietary guidelines for people living with 
TB, HIV/AIDS and other chronic debilitating conditions recommend that “Meat and dairy foods 
may be eaten daily” and “Eat dried beans, peas, lentils, peanuts or soya regularly” (DOH 2001).  
Sibusiso may be added to the diet as a good source of protein to prevent wasting and malnutrition.   
 
Protein is constantly broken down to amino acids and replaced in the body (Sizer & Whitney 2008, 
p186).  The quality of protein is judged according to the amino acid composition of a product 
[Centers for Disease Control and Prevention (CDC) 2012].  Sibusiso had a higher amount of all 
essential amino acids, especially lysine the amino acid known to be deficient in peanut based 







relatively rich in essential amino acids such as lysine compared to peanuts (Yeh et al 2002).  In 
order to compensate for deficient amino acids such as lysine from peanut pastes a peanut-soya 
mixture such as Sibusiso is produced with good quality protein (Anon 2003; Dubost et al 2003; 
Yeh et al 2002).  An increase in all essential amino acids in a peanut spread with 19 % roasted 
soybean added was observed in a study conducted by Yeh et al (2002).   
 
The fat content of Sibusiso was slightly lower than that of the commercial peanut butter.  This 
could be due to the addition of low fat soya extracts to the peanut butter paste.  A decreased fat 
content was reported with addition of any soy bean or soynut flour in a peanut butter spread 
(Mazaheri-Tehrani et al 2009; Yeh et al 2002).  In addition, peanuts are known to be a good source 
of fat as these contain 45 - 56% of oil (Andersen, Hill, Gorbet & Brodbeck 1998).  This could be 
another reason for a slightly higher content of fat in the commercial peanut butter.  However, when 
the fat content of Sibusiso was compared to that of existing ready-to-use supplements, Sibusiso had 




.  This shows that Sibusiso had more soya oil 
added into it compared to the vegetable oil added to the other supplements (Diva 2011; Diop, 
Dossou, Ndour, Briend & Wade 2003).  When the fat content of Sibusiso was compared to the 
WHO‟s specifications for fat in ready-to-use supplements, it was found that the fat in Sibusiso 
contributed more than the maximum of 60% of the total energy as stated by the WHO 
(WHO/WFP/SCN/UNICEF 2007).  Therefore, Sibusiso had more than enough fat as a ready-to-use 
supplement and had slightly more than the WHO recommendations.  When the fat content of 
Sibusiso (40.1 g/100 g) was compared to that of previously reported data (40.3 g/100 g) on the 
packaging of Sibusiso, there was no difference found.   
 
Sixty two percent of the energy (kJ) in Sibusiso is from the fat content.  Sibusiso had slightly lower 
gross energy than the commercial peanut butter.  This was expected as it was reported that peanut 
seeds are higher in energy due to the high fat content (Anderson et al 1998).  Sibusiso however, had 
sufficient energy and even more energy according to the WHO specifications of energy from ready-
to-use supplements (WHO/WFP/SCN/UNICEF 2007).  The gross energy of Sibusiso was also 




 making Sibusiso a good vehicle for providing 








The higher carbohydrate content in Sibusiso, compared to the commercial peanut butter may be due 
to the lower content of protein in Sibusiso compared to the commercial peanut butter.  
Carbohydrates contribute more than 27% of the energy in Sibusiso which makes Sibusiso a good 
energy source. The high carbohydrate content in Sibusiso could be the reason for the low NDF in 
Sibusiso.  Sibusiso contains four times lower NDF compared to the commercial peanut butter.  The 
low fibre content is preferable for a supplement aimed at malnourished individuals.  This is due to 
the effect that too much fibre consumption has on the bowel movement.  Fibre has been reported to 
increase the bowel movement frequency which increases the risk of diarrhoea among the vulnerable 
groups (Meier & Gassull 2004).  HIV infected individuals are vulnerable to diarrhoea which may 
be worsened when too much of fibre is consumed (Sizer & Whitney 2008, p112; Suttajit 2007).  An 
excessive intake of fibre may also result in chelation, a process where some vitamins and minerals 
are trapped in fibre and quickly pass out before absorption, thus increasing the risk for 
micronutrient deficiencies (Sizer & Whitney 2008, p114).  
 
The mineral content of Sibusiso was higher than that of the commercial peanut butter; this was 
similar to findings by Mazaheri-Tehrani et al (2009) in a study about fortified peanut spreads.  
According to the previously reported data on the package of Sibusiso, the product has been fortified 
with vitamins and minerals.  This increased expectations for a higher amount of minerals in 
Sibusiso (GOTG 2009).  Micronutrients are essential for immune recovery among HIV infected 
consumers (Kaiser, Campa, Ondercin, Leoung, Pless & Baum 2006).  Generally, HIV infected 
consumers experience micronutrient deficiencies especially during the early stages of the infection.  
Such deficiencies increase disease progression, the risk of opportunistic infections and the risk of 
death due to HIV related disease (Kaiser et al 2006).  The high level of micronutrients in Sibusiso 
may help to improve biochemical mechanisms in the body leading to functional organs and strong 
muscles.  Micronutrients may also improve wound healing and the immune system (Sriram & 
Lonchyna 2009).  Micronutrient supplementation for HIV infected individual and infected people 
on HIV treatment has been proven to be effective in improving the CD4 lymphocyte reconstitution 
(Kaiser et al 2006; Fawzi, Msamanga, Spiegelman, Kapiga, Villamor, Mwakagile, Mugusi, 
Hertzmark, Essex & Hunter 2004; Jiamton, Pepin, Suttent, Filteau, Mahakkanukrauh, 







5.2  Physical properties of Sibusiso 
 
The colour of Sibusiso was brown and similar to that of the commercial peanut butter, but slightly 
lighter.  This finding was similar to that of Yeh et al (2002) where the addition of soya to a peanut 
butter spread resulted in a lighter colour.  The colour of Sibusiso increases the acceptance to 
consumers who are familiar with the brown colour of peanut spreads.  The a* and b* values of 
Sibusiso suggested that the colour of Sibusiso was slightly less red and yellow compared to that of 
the commercial peanut butter.   
The texture of Sibusiso was almost as hard as that of the commercial peanut butter.  Sibusiso was 
however a bit harder and took more energy to compress compared to the commercial peanut butter.  
According to Dubost et al (2003), a harder and adhesive texture is expected from a product with a 
high amount of soy protein.  However, Sibusiso was slightly harder than the commercial peanut 
butter.  This shows that the amount of soya incorporated into Sibusiso was not sufficient to 
significantly affect hardness (Mazaheri-Tehrani et al 2009; Dubost 2001).  Sibusiso was more 
adhesive than the commercial peanut butter as it took more energy to overcome the forces of 
attraction between the surface of the spread and the probe (Szczesniak & Farkas 1962).  The results 
were expected as the addition of soy protein is said to give a harder and a more adhesive product 
(Mazaheri-Tehrani et al 2009; Dubost 2001).  Sibusiso was slightly stickier compared to the 
commercial peanut butter.  A spread with more fat content was reported to be the stickiest and 
softest in a descriptive analysis test however this was not true in this study as the commercial 
peanut butter had more fat (Yeh et al 2002).   
 
5.3. Consumer acceptability 
 
The high acceptability of Sibusiso by consumers treated for HIV and HIV/TB co-infection implied 
that the ARV and TB treatment did not have an effect on the perception of sensory properties of 
Sibusiso.  Physiological changes such as oesophageal thrush, lack of appetite, nausea and vomiting 
that were reported to have a negative effect on the consumer acceptability of food (Dibari et al 
2012) did not have a negative effect on the consumer acceptability of Sibusiso.  A lesser number of 
healthy consumers who liked Sibusiso may be due to a lack of interest in supplements and the fact 
that these consumers may not be in need of supplements.  Therefore, that may cause these 







acceptability of a ready-to-use supplement was also observed in a study that was conducted among 
HIV infected patients from Kenya (Bahwere et al 2009).  Another study conducted in Kenya using 
a peanut based ready-to-use supplement among adults treated for HIV and TB, reported a dislike 
for some properties of a supplement.  Consumers found the supplement to be unacceptably salty or 
too sweet (Dibari et al 2012).   
 
The high acceptability of taste and smell by healthy consumers in the study might be due to the 
unique peanut butter flavor from peanut containing foods (Nepote, Mestrallet, Olmedo, Ryan, 
Conci & Grosso 2008).  Even though the colour of Sibusiso was liked by most consumers, a lower 
number of healthy consumers liked the colour of Sibusiso.  The colour was similar to that of the 
commercial peanut butter.  The reason for the lower number of healthy consumers who liked the 
colour might be due to a high level of objectivity from the healthy group.  There were only a few 
consumers who said the colour was “bland”, however, the majority of consumers associated the 
colour of Sibusiso with that of a commercial peanut butter which was in agreement with other 
studies (Dubost et al 2003).   
 
The majority of both the HIV and HIV/TB co-infection treated consumers liked the mouthfeel or 
texture of Sibusiso as the average score was 4 representing „good‟.  The lesser number of healthy 
consumers who liked the mouthfeel of Sibusiso may be due to the high level of sensitivity to taste 
by the healthy consumers.  Sibusiso was found acceptable across all adult age groups however, the 
high level of acceptance of the taste, smell, colour and the mouthfeel of Sibusiso decreased among 
the younger consumers (18 – 25 years old).  The number of the ≥ 46 year olds who liked colour and 
the mouthfeel also decreased among the older group.  This implied that the middle age group (26 – 
45 years of age) may be open to new products compared to the younger group.  It was reported that 
as an individual grows older the sensitivity to sensory properties decreases (Koskinen & Tuorila 
2005; Schiffmann & Graham 2000; Zandstra & de Graaf 1998).  
 
5.4  Focus group discussions 
 
In the focus group discussions, Sibusiso was associated with the most used spreads in different 
households.  As an acceptable spread Sibusiso may easily blend with the diet of the HIV and 







associated the taste, smell, colour and the mouthfeel of Sibusiso with that of peanut butter.  The 
majority of consumers had a positive attitude towards the sensory attributes of Sibusiso.  Even 
though the majority of consumers liked the taste of Sibusiso some consumers from both the HIV 
and the HIV/TB groups associated the taste of Sibusiso with that of a porridge received from the 
clinic.  The taste of the porridge associated with Sibusiso was said to be “nice” which therefore 
implied a positive attitude towards the taste of Sibusiso by consumers.  Changes of the taste and 
smell sensations of patients on medication and experiencing side effects may also interfere with 
consumer‟s judgment of these attributes (Augustus 1997).  
Regarding the texture of Sibusiso some consumers said the texture was “like maize with oil”, 
“rough”, “like powder porridge with oil added” and “crunchy”.  These different views about the 
texture might be the reason for a lower number of consumers who liked the mouthfeel from the 
sensory evaluation.  The views are also in line with the instrumental results which showed that 
Sibusiso was slightly harder than the commercial peanut butter.  The graininess of soya could be 
the reason for the poor acceptance of texture by consumers.  Dibari et al (2012) also found some 
consumers who had difficulties swallowing a ready-to-use-supplement due to its consistency.  
Consumers suggested that the texture of Sibusiso should be made smoother.  Such views were also 
reported from a study by Bouwer & Bosman (2008) where HIV consumers preferred a more runny 
porridge when given two instant soy maize and instant plain maize porridge supplements.  
Consumers suggested a change in texture due to oral lesions experienced by HIV patients which 
may affect chewing and swallowing (Bouwer & Bosman 2008).  Dubost et al 2003 also reported 
that 67% of healthy consumers preferred a smooth peanut butter spread than the one with a crunchy 
texture.  
In response to the question of willingness to buy the supplement, a few consumers expressed some 
willingness to buy Sibusiso. The majority however, stated that they would like the product to be 
given for free at the clinic as part of the ART program.  The high dependence of HIV and TB 
treated consumers on receiving dietary supplements from the government hospitals or clinics may 
interfere with consumers‟ willingness to purchase supplements.  This study revealed that the 
majority of consumers received free supplements from the health care facilities.  Only consumers 
that have used Sibusiso before and experienced its benefits were willing to pay for it.  It was 
observed that consumers were willing to pay more for normal spreads but were not willing to pay 







willing to pay more for a fortified product (Mabaya et al 2010; Spence & Townsend 2007).  
Consumers were worried that they would need more than one 500 g tub of Sibusiso (R60.00) per 
month and that the tub would be shared in the household therefore would be more expensive to 
sustain.  The reluctance towards buying could be due to the low economic status of the majority of 
participants and their high sensitivity to price (Mabaya et al 2010).  The lack of knowledge about 
the importance of supplements and what supplements are was observed.  This highlighted the 
importance of conducting nutrition education among HIV and HIV/TB treated consumers about 
what supplements are and their benefits.  
 
Unlike in most studies the majority of consumers in this study were not worried about being 
stigmatised when given dietary supplements (Dibari et al 2012; Ndekha et al 2009).  This may be 
due to the fact that most participants were comfortable with their status and had no fear of being 
judged.  It could also be that participants were hoping to be given samples after participating in the 
study therefore wanted to sound confident.  However consumers mentioned that at their early stage 
of diagnosis they were afraid to receive dietary supplements as the disease was still new to them.  
Stigmatisation has been found to affect HIV and HIV/TB infected individual‟s intake of dietary 
supplements and compliance with medication (Dibari et al 2012).   
 
The results from this study should be interpreted with caution due to the small size of the consumer 
sample and the racial imbalance.  Most participants in the study were at the recovery stage of 
HIV/AIDS and were not experiencing severe symptoms of the infection especially in the mouth.  
Such symptoms could affect consumer perception of sensory attributes therefore, it is important to 
be considerate of the HIV stages of consumers when interpreting these results.  This study was also 
cross-sectional therefore did not assess consumer‟s perceptions of the product over time.  
Therefore, it would be advisable to assess perceptions of the product taken over a longer period 











CONCLUSIONS AND RECOMMENDATIONS 
 
In this chapter, conclusions and recommendations from this study are discussed.  The aim of this 
study was to determine the nutritional composition and physical properties of a locally produced 
ready-to-use supplementary food Sibusiso.  It also aimed to assess the sensory acceptability and 
perceptions of this supplementary food by healthy consumers and consumers treated for HIV and 
HIV/TB co-infection. 
6.1  Conclusions  
Sibusiso is a better source of carbohydrates and ash compared to the commercial peanut butter.  It 
is also a source of good quality protein in terms of essential amino acids, fats, minerals and energy 
according to WHO specifications for ready-to-use supplements.  Thus, Sibusiso has the potential to 
prevent and alleviate malnutrition among adult individuals infected with HIV or HIV/TB co-
infection.   
In terms of physical properties, Sibusiso appears brown in colour similar to commercial peanut 
butter.  Sibusiso seems to be slightly harder and stickier than the commercial peanut butter.  This 
could be because of the addition of soya to Sibusiso compared to commercial peanut butter which 
contains no soya.   
Sibusiso was found to be highly acceptable to HIV and HIV/TB co-infected consumers.  HIV and 
HIV/TB co-infected consumers reported that sensory attributes of Sibusiso were similar to that of a 
peanut butter.  HIV and HIV/TB co-infected consumers liked the taste, smell, colour and the 
mouthfeel of Sibusiso similar to the healthy consumers who liked all sensory attributes.  The 
similarity of physical properties of Sibusiso with that of a commercial peanut butter could be the 
reason for its remarkable acceptability among HIV and HIV/TB co-infected adult consumers as 
well as the healthy consumers.  Sibusiso was acceptable across age groups from the 18 year olds to 
the ≥ 46 year olds.  The high acceptability of sensory properties of Sibusiso suggests that Sibusiso 
has the potential to alleviate malnutrition and to help improve the nutritional status of consumers 







However, consumers may not afford the product as it appears expensive (R60.00/ 500 g of 
Sibusiso).  Most vulnerable groups such as HIV and HIV/TB co-infected people have a poor 
financial status.  This was confirmed in this study as the majority of consumers sampled were 
unemployed and depended almost entirely on government grants.  Surprisingly, consumers spent 
more money on normal commercial spreads compared to what they would spend on supplements 
such as Sibusiso.  This implies that nutrition programmes need to focus more on educating 
consumers about nutrient-dense foods.  Sibusiso proved to be a good source of macro- and 
micronutrients.  Therefore, it can be used by HIV and HIV/TB co-infected consumers as a ready-
to-use supplement to effectively provide necessary nutrients and alleviate diseases or conditions 
related to malnutrition.   
6.2  Recommendations  
Although this study showed Sibusiso to be rich in macro- and micronutrients further research needs 
to be done to assess the effect of Sibusiso on the nutritional status of HIV and HIV/TB infected 
adults.  The HIV and HIV/TB patients suggested a slight change in the texture of Sibusiso from a 
rough feel to relatively smooth.  This was suggested by consumers who might have had a problem 
with swallowing Sibusiso.  Improving the texture may increase the level of acceptability of the 
mouthfeel by the younger age group (18 - 25 years).   
HIV/AIDS and HIV/TB consumers showed a lack of knowledge about dietary supplements, their 
importance and potential benefits in comparison to commercial spreads.  Therefore, these 
consumers need to be educated about dietary supplements and how normal spreads may be 
substituted with supplements such as Sibusiso, supplements with high nutritional composition and 
better nutritional benefits.   
This study has highlighted the need for the manufacturer to research different ways in which the 
product may be made more acceptable and more affordable.  It also exposed the need for future 
research to look at different ways of making Sibusiso more affordable and accessible to consumers 
of diverse financial backgrounds.  Because of the potential Sibusiso has to improve the nutritional 
status of malnourished individuals, it is recommended that the government consider this product to 
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INVITATION TO A SENSORY EVALUATION 
 
 
You are invited to participate in a tasting study conducted by Human 
Nutrition Masters students from the University of KwaZulu-Natal. 
 
 






The tasting and evaluation should take 20 minutes. Participation is 
voluntary and you can choose to withdraw at any time during the study. 
 
 
For further information you can contact Dr Siwela at 033 260 5459 or at 


















Uyamenywa ukuba ingxenye yocwaningo lokuhlola ukwamukeleka kokudla 










Lolucwaningo lungathatha imizuzu engama-20.  Ukuba yingxenye 
yalolucwaningo kusothandweni lakho futhi unelungelo lokuhoxa noma ngabe 
inini uma uthanda. 
 
 
Ngemininingwane noma imibuzo mayelana nocwaningo ungaxhumana no-Dr 
Siwela ku-033 260 5459 noma SiwelaM@ukzn.ac.za, noma u-Bongi ku-082 269 








APPENDIX C: CONSENT DOCUMENT FOR ALL PARTICIPANTS IN ENGLISH 
 
INFORMED CONSENT TO PARTICIPATE IN RESEARCH 
 
My name is Bongekile Mabaso, a Masters of Science in Human Nutrition student at the University 
of KwaZulu-Natal.  I would like you to participate in a study entitled: The sensory evaluation of a 
ready-to-use food supplement by adults in Pietermaritzburg, KwaZulu-Natal (KZN).  This study 
is conducted in fulfilment of my Masters of Science dissertation.  In this study you will be required 
to eat a peanut based food supplement and then indicate and comment on what you think of the 
taste, texture, smell, colour and the overall acceptability.   
Participation in this study is voluntary and should you want to withdraw you can do so at any point.  
Please read the information below and ask questions if there is anything you do not understand.   
 
The purpose of the study 
Malnutrition, which is either the lack of required nutrients or an excess intake of nutrients can 
cause heath conditions or diseases. Introducing fortified foods like the ready-to-use food 
supplement used in this study may improve the nutritional status of people and therefore their 
health.  However, it is important to know whether people will accept the food supplement or not.  It 
is for this reason you are being asked to participate in this study.  
 
It is important to know that:  
 You will be required not to smoke 30 minutes before participation; 
 Participation is free and there will be no prize given; 
 There are no risks unless you are allergic to nuts;  
 All information will be kept confidentially and in line with the standard of the  
UKZN research ethics committee; and 
 
Should you have any questions related to the study, please contact the supervisor of the study, Professor 











_______________     





If you agree to participate in this study please sign the consent form. 
 
I hereby declare that I understand the above information.  I was satisfied by the way my questions were 
answered. 
I also understand the purpose and benefits of the study as well as my role in the study. 
 
Furthermore, I understand that it is my responsibility to inform the researcher about any allergies I may 
have.  I also understand that there will be no risks or discomforts from the study and that I may 
withdraw from the study at any time without any consequences. 
 
________________________________________ 
Printed Name of Subject 
 
 
________________________________________  _________________________ 










APPENDIX D: CONSENT DOCUMENT FOR ALL PARTICIPANTS IN ISIZULU 
 
Igama lami nginguBongekile Mabaso, umfundi we-Masters of Science in Human Nutrition 
eNyuvesi yaKwaZul-Natal.  Ngicela ukuba ubeyinxhenye yocwaningo olusihloko sithi: The 
sensory evaluation of a ready-to-use food supplement by adults in Pietermaritzburg, KwaZulu-
Natal (KZN).  Lolucwaningo ngilenza ngenhloso yokuthola iziqu ze-Masters of Science eNyuvesi 
yaKwaZulu-Natal.  Kulolucwaningo uzocelwa ukuba udle ukudla okwenziwe ngamakinati 
okunothiswe ngomnotho bese uyasho futhi uchaze ukuthi ucabangani ngendlela okunambitheka 
ngayo, okunuka ngayo, umbala wakho, nangendlela okuzwakala ngayo uma ukuthinta kanye 
nokwamukeleka kwakho.  Ukuba inxhenye yalolucwaningo kudingeka ukwenze ngaphandle 
kokulindela inzuzo futhi ungahoxa noma inini uma ungasathandi.  Ngicela ufunde imininingwane 
elandelayo bese ubuza uma kukhona ongakuzwa kahle.  
Inhloso yalolucwaningo 
Ukusweleka komsoco noma izakhamzimba kanye nokuba nakho kubekuningi kakhulu emzimbeni 
kungadala izinkinga zezempilo kanye nezifo.  Ukuba nokudla okulungele ukudliwa okunothiswe 
ngezakhambimba nomcoso ama “ready-to-use food supplement” kungavuselela ukondleka 
kwabadinga umsoco, kwevuselele impilo.  Kodwa-ke, kubalulekile ukwazi ukuthi lokhu ukudla 
kuzokwamukeleka na emphakathini noma cha.  Yingakho-ke kubalulekile futhi ucelwa ukuba ube 
ingxenye yalolucwaningo. 
Kubalulekile wazi okulandelayo ngaphambi kokubayinxhenye yocwaningo: 
 Kudingeka ukuthi ungabhemi emizuzwini engama-30 ngaphambi kocwaningo; 
 Awukho umklomelo ozotholwa futhi uyavolontiya; 
 Abukho ubungozi ngaphandle uma uguliswa amakinati; 
 Yonke imininingwane eqoqwe ocwaningweni izogcinwa njengemfihlo kulandelwa 
imigomo yokugcina ulwazi yekomidi locwaningo yaseNyuvezi yaKwaZulu-Natal. 
Uma unemibuzo mayelana nocwaningo ungaxhumana nomqaphi wocwaningo u-Professor 











_______________     





Uma uvuma ukuba inxhenye yocwaningo sicela ugcwalise ifomu elingenzansi. 
Ngiyavuma ukuthi ngiyizwa kahle yonke imininingwaneechazwe ngenhla.  Nginelisekile ngendlela 
imibuzo yami ephendulwe ngayo. 
Ngiyayazi inhloso yalolucwaningo nokuthi luzosiza kanjani nokuthi mina ngizosiza kanjani noma 
ukuthi ngizokwenzani.   
 
Okunye, ngiyazi ukuthi kungumsebenzi wami ukwazisa umcwaningi ngokudla okungigulisayo.  
Ngiyaqonda futhi ukuthi abukho ubungozi ekubeni inxhenye yocwaningo futhi ngingahoxa nama inini 




________________________________________  _________________________ 














APPENDIX E: FIVE-POINT FACIAL HEDONIC SCALE IN ENGLISH 
 
 
Consumer acceptability questionnaire  
  
 







Please assess the food sample in front of you. Then indicate how you feel about the taste, smell, 
colour, mouth feel and the overall acceptability by placing a cross over the face indicating your 
liking. 
 
Please rinse your mouth with water before starting. You may rinse again at any time during the test 























































































































APPENDIX F: FIVE-POINT FACIAL HEDONIC SCALE IN ISIZULU 
 
Consumer acceptability questionnaire  
  
 









Hlola ukudla okuphambi kwakho.  Shono ukuthi ucabangani ngendlela okunambitheka ngayo, 
iphunga, umbala, indlela okuzwakala ngayo emlonyeni kanye nendlela okuthanda ngayo nje.  
Khombisa lokhu ngokubeka uphawu [X] eduze kobuso obuqondene nomuzwa wakho. 
 
Yakaza umlomo ngaphambi kokuba uqale. 
Ungayakaza futhi nanoma ngasiphi isikhathi ngenkathi uhlola lokudla.. 


















































































































































APPENDIX G: FOCUS GROUP DISCUSSION QUESTIONS IN ENGLISH 
FOCUS GROUP GUIDE: THE EVALUTION OF A READY-TO-USE FORTIFIED FOOD 
SUPPLEMENT 
Specify the group first if they have eaten the product or not. 
1. CONSUMER PERCEPTIONS TOWARDS SPREADS: Consumer experiences and 
preferences of spreads and supplements 
 Name all types of bread spreads you know & use.  State why they are most liked or least liked 
and who likes them from the household. 
[Rank these in order according to the most liked by the consumers and explain why they 
were the most liked; this question should also indicate which category of the persons in 
household like or least like each spread]   
 Give all the types of supplements you know & use.   State why they are most liked or least 
liked. 
(Rank these in order according to the most liked by the consumers and explain why they 
were the most liked) 
 Give all the types of immune boosters you know & use.  State why they are most liked or least 
liked. 
(Rank these in order according to the most liked by the consumers and explain why they 
were the most liked) 
2. CONSUMER EXPECTATIONS and PREFERENCES: What influences consumer to 
consume a product (Assessment of the best valued food product component)  
 How do you expect peanut paste to taste, smell, look (colour) like? 
 If someone brings to you a consumable product such as the peanut paste, what would you do 
and or what kind of questions would you ask? (Physical component, nutritional content or 
affordability) 
  
3. CONSUMER PERCEPTIONS TOWARDS PEANUT PASTE: Consumer sensory 
characteristics  
 With regards to the peanut paste in front of you, how would you describe its physical 







4. If one of the above mentioned physical components does not meet your sensory expectations, 
how would you like it to be improved? 
 
5. PEANUT PASTE CONSUMER ACCEPTABILITY 
 If the peanut paste could be commercialized would you buy it? Elaborate  
 How would you use it in your household and who would you give it to most? Why 
 (We want to know whether they use as a spread, add on their porridge etc.) 
6. CONSUMER WILLINGNESS TO BUY 
 How much would you pay for the peanut paste? (Take the average prices mentioned or the 






































APPENDIX H: FOCUS GROUP DISCUSSION QUESTIONS IN ISIZULU 
FOCUS GROUP GUIDE: THE EVALUTION OF A READY-TO-USE FORTIFIED FOOD 
SUPPLEMENT 
1. IMICABANGO YABANTU NGEZINTO ZOKUGCOBA ISINKWA.  
 Shona zonke izinhlobo zezinto zokugcoba isinkwa ozaziyo nozisebenzisayo.  Chaza ukuthi 
iziphi ozithanda kakhulu, nozithanda kancane shona futhi ukuthi ngubani ozithanda kakhulu 
ekhaya        
 Shona zonke izinhloba zezakhamuzimba okukanye ukudla okunothiswe ngomsoco ozaziyo 
nozisebenzisayo.  Chaza ukuthi iziphi ozithanda kakhulu, nozithanda kancane shona futhi 
ukuthi ngubani ozithanda kakhulu ekhaya. 
 Shona wonke ama-immune booster okanye izakhamasotsha ozaziyo nozisebenzisayo.  Chaza 
ukuthi iziphi ozithanda kakhulu, nozithanda kancane shona futhi ukuthi ngubani ozithanda 
kakhulu ekhaya.         
 Chaza ukuthi imalini oyisebenzisa ukuthenga lemikiqizo. 
 
2. OKULINDELWE KANYE NOKUNCAMELWAYO: Yini ekhuyhaza abanyu ukuthi 
badle ukudla abakudlayo 
 Ingabe ulindele ukuthi i-paste eyenziwe ngamakinati inambitheke, inuke futhi ibenombala 
onjani? 
 Uma unganikezwa umkhiqizo owenziwe ngamakinati ukuthi uwudle, ungenza njani futhi 
imiphi imibuzo ongayibuza? 
 
3. IMICABANGO YABANTU NGESIGCOBO ESENZIWE NGAMAKINATI  
 Uma uhlaziya lokudla onikiwe.   Ungakuchaza kanjani ukunambitheka, iphunga, i-texture 
kanye nombala kwakho? 
 Uma okunye kwalokhu okubalwe ngenhla kungenjengoba ulindele ungafisa ukuthi kushintshwe 
kanjani? 
 
4. UKWAMUKELEKA KWE-PEANUT PASTE NGABANTU  
 Uma ukudla okuphambi kwakho kungadayiswa ezitolo, ungakuthenga?  Naba. 








5. UKULANGAZELELA KWABANTU UKUTHENGA UKUDLA 









APPENDIX I: DEMOGRAPHIC INFORMATION QUESTIONNAIRE IN ENGLISH 
DEMOGRAPHIC INFORMATION FOR FOCUS GROUP PARTICIPANTS 
 
1. Name_______________________________________ 








Black            Coloured             Indian            White             other______________ 
  
5. Marital Status 
 
Married              Single             Divorced           Separated         Widow/widower  
 
6. How many people (including you) live in your house? _________ 
Indicate the number of people per age category by writing a number in a box. 
 
0-12 Months 1-5 years             5-17 years   
 
17-25 years            25-45 years          >45 years  
 
7. What is your highest level of education you have achieved? 
 
No schooling            Primary school            High school            College diploma             
 
Bachelor‟s degree            Master‟s degree             
 
8. What is your current employment standing? 
 




















9. Do you use any supplements? Yes              No            If yes please indicate below. 
 
           Vitamin A           Iron             Calcium             Multivitamin   
           Porridge          Sibusiso              Other (s) ______________________________________ 
10.  Where do you source or get your supplements from? 
 
Clinics             Hospitals           Pharmacy   
 
Doctor             Supermarket            Other (s) ____________________________________ 
 
11. If you buy supplement(s), how much do you spend on them? __________________ 
 
12. How often do you buy or receive supplements? I buy           or receive          supplements: 
 
Every week            Every 2 weeks           Monthly             Other(s) __________________ 
 
13. Please indicate the type or quantity you buy or are given. 
 





















APPENDIX J:  DEMOGRAPHIC INFORMATION QUESTIONNAIRE IN ISIZULU 
DEMOGRAPHIC INFORMATION FOR FOCUS GROUP PARTICIPANTS 
 
1. Igama_______________________________________ 








Nsundu            Khaladi             Ndiya             
 
Mhlophe              Nolunye_______________________ 
  
5. Isimo sokushada 
 
Ngishadile            Singili             Ngihlukanisile            Umfelwa/ umfelwakazi    
 
6. Nibangakhi ekhaya uma uzibala nawe? _________ 
Khombisa inombolo yabantu ngokweminyaka ngokubhala inombolo ebhokisini noma 
emabhokisini afanele. 
 
0-12 Months 1-5 years             5-17 years   
 
17-25 years            25-45 years          >45 years  
 
7. Iliphi izinga lokufunda eliphezulu onalo?   
 
Angiyanga esikoleni         Amazinga aphansi            Amazinga aphezulu             
 
Ikolishi             I-degree            I-master‟s degree          
 
8. Isimo sakho somsebenzi sime kanjani njengamanje?  
 
















9. Ingabe uyazisebenzisa izakhamuzimba, ama-supplement? Yebo         Cha        .  Uma 
impendulo kunguyebo khombisa ngenzansi.   
 
           Vitamin A           Iron           Calcium            Multivitamins 
           Iphalishi             Sibusiso              Ezinye ______________________________________ 
10.  Ingabe uzithola kuphi izakhamzimba noma ama-supplement akho? 
 
Emtholampilo            Esibhedlela           Ekhemisi   
 
Kwadokotela          Esuphamakethe          Noma e_________________________ 
 
11. Uma uzithenga izakhamzimba noma ama-supplement, uchitha malini kuzo? 
__________________ 
 
12. Ingabe uzamukela noma uzithenga kangakanani izakhamzimba?  Ngizamukela  
Noma ngizithenga          : 
 
Masontonke           Njalo emvakwamasonto amabili  Nyangazonke  
Noma e________________________________________ 
 
13. Khombisa inhlobo noma inani olitholayo noma olamukelayo. 
 























APPENDIX K: LETTER OF ETHICS APPROVAL FROM THE HUMANITIES  
   AND SOCIAL SCIENCES ETHICS COMMITTEE, UNIVERSITY OF  














APPENDIX L: LETTER OF APPROVAL TO CONDUCT RESEARCH AT GREY’S  













APPENDIX M: LETTER OF APROVAL TO CONDUCT RESEARCH AT NORTHDALE 
      CLINIC 
 
 
 
 
